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Summary 
 
For medicine to advance such that it would be possible to regenerate tissue after illness or injury, it is necessary 
both to achieve a better understanding of human physiology and to apply engineering techniques. The field 
dedicated to these goals and this type of approach is tissue engineering. The most common approach to forming 
tissues in vitro is by creating scaffolds with specific characteristics and then seeding the surface with selected 
cell types. As the field of tissue engineering has progressed, and there is more evidence indicating that this 
approach alone is not satisfactory, more elegant tactics have arisen. Biofabrication is the simultaneous 
processing of biomaterials, cells and other biologically active agents to form constructs that have biological 
functions. However, one of the major bottlenecks for biofabrication is appropriate biomaterials, which has made 
biomaterial development for biofabrication of significant relevance.  
 
Spider silk is a valuable natural resource for high-performance textiles due to its mechanical toughness and 
stability. More recently, it has not only been valued for its use as a textile, but for its use as a biomaterial. 
However, natural spider silk suffers from batch-to-batch variability, and farming of spiders is difficult as they are 
cannibalistic. A solution to this problem is to produce recombinant spider silk protein. The key characteristics of 
natural spider silk are captured in the sixteen repeats of a spider silk protein amino acid sequence, the C 
module, that constitute the engineered spider silk protein Araneus diadematus fibroin 4 (eADF4(C16)), which 
exhibits similar toughness to natural spider silk, hypoallergenicity and biocompatibility, and can be produced 
consistently in large quantities. Moreover, it can be modified with the cell binding peptide RGD to promote cell 
attachment onto various scaffolds produced of eADF4(C16)-RGD. For this reason, this protein was investigated 
for use as a cell-loaded hydrogel for 3D bioprinting, that is, as a bioink. This approach proved to be promising 
and inspired subsequent work with these proteins as a biomaterial for biofabrication. 
 
The purpose of this work was to develop different biofabrication techniques using the recombinant spider silk 
protein eADF4(C16), in particular to develop bioinks for 3D printing and for biologically-friendly dopes for 
electrospinning. The motivation for combining these two approaches is that they complement each other. 3D 
bioprinting allows for precise deposition of cell-loaded hydrogels into complex macrostructures whereas 
electrospinning produces fibers in the nano- to micron- range. These two approaches together, therefore, can 
cover a broad spectrum of scaffold features. 
 
Although eADF4(C16) has already been used to produce electrospun mats for fine particle filters and in vitro cell 
culture, the processing conditions have not been biocompatible. Therefore, an aqueous electrospinning dope 
was developed using highly concentrated eADF4(C16) solution and 400 kDa poly(ethylene oxide) (PEO) as an 
additive. Furthermore, the post-treatment method was modified from ethanol vapor treatment at 60 °C to water 
vapor treatment at 37 °C. Using green fluorescent protein (GFP) as a model for a biological active agent, it was 
demonstrated that GFP remained fluorescent using the all-aqueous processing route. However, fluorescence 
activity was diminished when added to the traditional spinning dope containing hexafluoroisopropanol (HFIP), or 
when post-treated by ethanol, thereby demonstrating the significance of the all-aqueous electrospinning route. 
ii 
 
 
eADF4(C16) and eADF4(C16)-RGD bioinks were also developed and characterized in this work. By simple 
observation, it was clear that both the addition of cell culture media and the RGD peptide sequence have an 
effect on the final properties of the bioinks. It was found that RGD increases the stiffness and the gelation rate of 
the bioinks, when compared to the same concentration of eADF4(C16), however the addition of cell culture 
media had a more pronounced effect in terms of increasing the gelation rate and stiffness. After the bioinks were 
characterized based on their formulation, they were optimized for 3D cell culture. By changing the seeding 
regime, it was possible to have 100 % cell viability after encapsulation, and the cells were also able to proliferate 
in eADF4(C16)-RGD bioinks. By simply blending with a low amount of unmodified gelatin the resolution of the 
printed bioinks were improved, although the cells had reduced viability and proliferation post-printing.  
 
Overall, through this work it was shown that the recombinant spider silk protein eADF4(C16) is a versatile 
biomaterial for biofabrication. In particular, it was successfully used for electrospinning biologically active 
nonwovens and as a platform for 3D cell culture. Possible future work could include using other variants of the 
protein to tailor the release of biologicals from electrospun nonwovens, or to promote certain cell behaviors, or to 
adapt bioink properties. Furthermore, these two types of processing could be used together to create composite 
scaffolds with variable morphologies. 
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Zusammenfassung 
 
Ein besseres Verständnis der menschlichen Physiologie und die Anwendung von Ingenieurstechniken sind 
notwendig, um die Medizin soweit voranzutreiben, dass die Heilung von durch Krankheit oder Verletzung von 
geschädigtem Gewebe möglich ist. Dieses Aufgabengebiet und diese Methoden werden dem Fachbereich oder 
-gebiet Tissue-Engineering (TE), (z.Dt. die künstliche Herstellung biologischen Gewebes) zugewiesen. Die 
häufigste Herangehensweise, um Gewebe in vitro herzustellen, ist es dies nach spezifischen Vorgaben 
herzustellen und anschließender mit den gewünschten Zelltypen zu besiedeln. Die Fortschritte auf dem Gebiet 
des TE zeigen weisen zunehmend darauf hin, dass diese Arbeitsweise alleine nicht ausreicht, um biologisch 
funktionelle Materialien herzustellen. Demzufolge sind vielseitige Ansätze entstanden, um das Ziel vollständiger 
Geweberegenerierung zu erreichen. Ein vielversprechendes neues Verfahren ist die Biofabrikation, welche die 
gleichzeitige Verarbeitung von Biomaterialien, Zellen und anderen biologisch aktiven Substanzen für die 
Erzeugung von künstlichem Gewebe nutzt. Jedoch gibt es in der Biofabrikation bis dato wenige geeignete 
Biomaterialien, folglich wird der Entwicklung von Biomaterialien für die Biofabrikation eine hohe Relevanz und 
Bedeutung zugesprochen. 
 
Seit Hunderten von Jahren wird natürliche Spinnenseide auf Grund der hervorragenden mechanischen 
Eigenschaften (Zugfestigkeit und Dehnbarkeit) als außerordentliches Material (z.B. Textilien) verwendet. . Seit 
Kurzem findet Spinnenseide nicht nur in der Textilbranche sondern auch als Biomaterial seine Anwendung. 
Natürliche Spinnenseide leidet jedoch unter Qualitätsschwankungen und die Gewinnung von natürlicher 
Spinnenseide gestaltet sich schwierig wegen des Kannibalismus der Tiere. Ein Lösungsansatz hierfür ist die 
rekombinante Produktion von Spinnenseidenproteinen. Die wichtigsten Eigenschaften der natürlichen 
Spinnenseide wurden in einer künstlichen Aminosäuresequenz (dem C Modul) sechzehn Mal wiederholt und das 
künstliche Spinnenseidenprotein „engineered“ Araneus diadematus Fibroin 4 (eADF4(C16)) daraus gebildet. 
Dieses Protein besitzt ähnliche Eigenschaften wie das natürliche Spinnenseidenprotein hinsichtlich der 
Zähigkeit, Biokompatibilität und Immunantwort und kann zusätzlich in konstanter Qualität in großen Mengen 
produziert werden. Des Weiteren kann eADF4(C16) mit der zellbindenden Aminosäuresequenz 
“RGD“ modifiziert werden, um die Zellanlagerung an unterschiedlichen Morphologien zu verbessern. Deshalb 
war es möglich lebende Zellen in Hydrogele aus diesem Protein einzubetten. Dieses Material wird 
“Biotinte“ genannt und für den 3-D Druck untersucht. Diese Herangehensweise erwies sich als vielversprechend 
und dient als Richtlinie für das weitere Arbeiten mit diesen Proteinen als Biomaterial. 
 
Ziel dieser Arbeit war es unterschiedliche Techniken, mit besonderem Augenmerk auf Biotinten für den 3D-Druck 
und Spinnlösungen für biologisch kompatibles Elektrospinnen, mit dem künstlichen Spinnenseidenprotein 
eADF4(C16) in der Biofabrikation zu entwickeln. Die treibende Kraft hinter der Kombination dieser beiden 
Technicken/Verfahren ist, dass sie sich gegenseitig ergänzen. Während das 3-D-Drucken das präzise Auftragen 
von Biotinte zu komplexe Makrostrukturen erlaubt, bildet das Elektrospinnen Fasern im Nano- bis 
Mikrometerbereich. Diese zwei Methoden können demzufolge eine weite Bandbreite von Eigenschaften für 
Zellträger abdecken. 
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Obwohl elektrogesponnene Vliesstoffe aus eADF4(C16) schon für Kleinpartikelfilter und in vitro Zellkultur 
verwendet wurden, waren die Verarbeitungsbedingungen bis jetzt nicht biokompatibel. In dieser Arbeit wurde 
eine hochkonzentrierte wässrige Spinnlösung mit 400 kDa Poly(ethylenoxid) als Zusatz entwickelt und 
dementsprechenddie Nachbehandlungsmethode von Ethanoldampf bei 60°C durch Wasserdampf bei 37°C 
ersetzt. Da unteranderem mitbiologisch aktiven Substanz wie zum Beispiel dem grün fluoreszierenden Protein 
(GFP) gearbeitet wurde, basiert der Prozess komplett auf wässriger Ebene, um die Aktivität das 
Fluoreszenzfarbstoffes zu erhalten. Ferner wurde gezeigt, dass die herkömmlichen Spinnlösung mit 
Hexafluorisopropanol (HFIP) und die Nachbehandlung mit Ethanoldampf die Fluoreszenzintensität – verringert.  
 
Zusätzlich wurden in dieser Arbeit eADF4(C16) und eADF4(C16)-RGD Biotinten weiterentwickelt und 
charakterisiert. Einfache Beobachtungen haben ergeben, dass das Zellkulturmedium sowie das RGD-Peptid die 
Eigenschaften der Biotinten beeinflussen. Es wurde festgestellt, dass das RGD-Peptid in eADF4(C16)-RGD die 
Steifigkeit und die Gelierungsrate im Vergleich zu eADF4(C16) in gleicher Konzentration erhöht, jedoch die 
Zugabe von Zellkulturmedium noch deutlichere Auswirkungen auf diese Eigenschaften zeigte. Nachdem die 
Zusammensetzung der Biotinten charakterisiert wurde, wurden sie für 3D-Zellkultur optimiert. Eine Änderung 
des Protokolls für die Zellbesiedelung ermöglichte eine 100%-ige Zellviabilität, sowie Zellproliferation nach dem 
Einbetten in eADF3(C16)-RGD Biotinte. Durch einfache Zugabe einer geringen Menge Gelatine konnte die 
Auflösung der gedruckten Biotinten verbessert werden, jedoch wiesen die Zellen reduzierte Viabilität und 
Proliferation nach dem 3D-Druck auf.  
 
Insgesamt konnte durch diese Arbeit gezeigt werden, dass das rekombinate Spinnenseidenprotein eADF4(C16) 
für die Biofabrikation ein vielseitig einsetzbares Material ist. Insbesondere konnte es erfolgreich zum 
Elektrospinnen von biologisch aktiven Vliesstoffen und als Trägermaterial für 3D-Zellkultur verwendet werden. 
Künftige Arbeiten können unter Anderem unterschiedlich modifizierte Varianten des Proteins untersuchen, um 
die Freisetzung von biologischen Wirkstoffen aus elektrogesponnenen Vliesstoffen anzupassen und 
ausgewähltes Zellverhalten zu fördern oder Eigenschaften von Biotinten zu regulieren. Darüber hinaus könnten 
diese zwei Verarbeitungsmethoden verwendet werden, um zusammengesetzte Zellträgermaterialien 
unterschiedlicher Morphologien zu kreieren. 
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1. Introduction 
 
Ageing, illness and injury are inevitable human sorrows, and it is therefore not surprising that the search for the 
fountain of youth continues, albeit not in the literal sense. Rather than find the fountain of youth, modern 
scientists and engineers are striving to create it. In spite of the many years spent pursuing this endeavor, we are 
far away from vaccinating all diseases, curing cancer or achieving complete wound regeneration, however, 
astounding progress has been made. With modern medicine, it is possible to alleviate pain, symptoms, and to 
improve prognosis for many medical complications, for example, tissue injury, tissue debilitation, organ failure, 
cardiovascular disease, cancer, nervous system injuries, and congenital disorders. However, most available 
products are non-curative; primarily drugs or implants made from artificial materials. This leaves patients 
dependent on treatment for long periods, if not their entire life. The field of regenerative and personalized 
medicine has therefore emerged in attempt treat the root cause of various afflictions. Regenerative medicine, or 
personalized medicine, is based on the principle that, by using a scientific understanding of the pathological 
state as well as the capacity of the human body to generate or self-heal (e.g. heal wounds, fight diseases, form a 
fetus), we can engineer products that allow the body to fully recover from any ailment. As stated by Mason and 
Dunnill, “regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish 
normal function” [1], which can be accomplished, for example, by using drugs, cell therapy, or tissue 
engineering. Tissue engineering is the combination of cells, biomaterials, and bioactive factors or stimuli to 
create tissue-like constructs with a desired functionality [2, 3]. Scaffolds are designed using either bottom-up or 
top-down approaches, as illustrated in Figure 1. 
 
 
Figure 1: Tissue engineering using cells, biomaterials and stimulation factors as ‘bui lding 
blocks’. Traditional tissue engineering is differentiated by top down or bottom up approach  
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The dogma of top-down approach is ‘shape equals function’, that is, the hypothesis is that controlling cell 
location and scaffold morphology will result in functional tissue formation. An example of this type of approach 
would be to form a biomaterial into the shape of blood vessel, and then seed relevant cell types in each 
compartment of the scaffold (intravascular, extravascular) [4]. The alternative hypothesis is that the best way to 
regenerate tissue is by taking a developmental biology approach. Proprietors of bottom-up approach use either a 
development biology approach, or combine these two concepts. The human embryo begins as a large mass of 
cells that matures into the developed fetus by properly responding to complex factors; therefore, the assumption 
is that engineered cells cultured in the proper environment should be able to engage in this sort of behavior for 
wound healing. An example of this approach would be cell growth directed by mechanical stimulus from external 
forces or by internal stresses that occur between cells themselves [5]. Alternatively, when both models are used, 
first cell-laden modules are developed, and then they are assembled or self-assembled into larger structures. An 
example of this is making microgels loaded with cells, maturing them, and then using microfluidics to fuse them 
together [6]. Biofabrication, a specific subset of bottom-up approaches in tissue engineering, is the simultaneous 
processing of cells and biomaterials into a bioactive constructs, Section 1.4. This type of fabrication imposes 
special requirements on biomaterials, in addition to those that are normally required. In the case of regenerative 
medicine, typically the objective is to make the biomaterial such that it imitates the extracellular matrix (ECM) of 
the tissue or tissue niche of interest in terms of the biomaterial’s biochemical composition and mechanical 
properties. ECM is the biopolymer network (matrix) surrounding cells (extracellular) which provides mechanical 
support, biological cues and many other functions to the tissue [7].  
 
1.1 Material design concepts for tissue engineering and biofabrication  
 
Materials are classified as ceramics, metals, polymers, or composites [8]. Composite materials being 
combinations of the three other material classes that result in a material with unique properties. Examples of 
these classic engineering materials are found everywhere, Figure 2. Other, more specialized material classes 
include semi-conductors (electrical conductivity properties between metal (conductor) and glass (insulator)) [9], 
smart materials (perform certain functions upon a particular stimulus) [10], and nanomaterials (nanoscale 
structures or fabrication) [11]. Biomaterials represent another specialized class of materials that interact with the 
human body to augment a tissue function or promote tissue formation, and there are examples of biomaterials in 
every materials classification, Figure 2. 
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Figure 2: Well-known examples of each material class: ceramics (left, blue boxes), metals 
(middle, yel low boxes), polymers (right, red boxes) and composites (middle, gradient color). 
Examples are further separated for traditional engineering materials (top, light gray box) and  
biomaterials (bottom, dark gray box).  
 
Ceramics and glasses are highly brittle materials composed of inorganic compounds that form a matrix mainly by 
covalent and ionic bonding. In terms of crystal structure, they can have any degree of crystallinity. For 
engineering, they are particularly valuable due to their electrical and thermal insulation, low friction, high 
mechanical strength and chemical resistance. Ceramics have therefore been traditionally used as fire-resistant 
utensils or parts of ovens. Modern applications for fiber reinforced ceramics include high performance composite 
materials (e.g. fiber-reinforced, high-performance brake pads) and thermal barrier layers (e.g. paneling on 
spaceships) [12, 13]. For biomedical engineering, technical ceramics are used for their low friction properties and 
biocompatibility as the joint for the hip implants [14], for their bone-conductive properties for bone tissue 
engineering (e.g. bioglass, bone graft pastes) and for dental implants [15]. Metals, on the other hand, have 
highly ordered atomic structure, but their electrons move freely in electron clouds. This leads to metals having a 
high strength to mass ratio, but also being malleable, ductile and fusible. These properties make metals ideal for 
load-bearing applications, for example as automotive parts [16]. Metals are usually electrically conductive, and 
their surfaces are chemically reactive (in particular they are sensitive to oxidization and corrosion when not pre-
treated), therefore they are also used for conducting electricity, and avoided for parts which come into contact 
with water, salts or harsh chemicals [9, 17]. For biomedical engineering, metals have many uses, which range 
from relatively simple devices such as surgical tools to complex ones such as implants. For example, metals 
have a high strength to mass ratio as well as tensile strength, which is appropriate for the stem of hip implants 
[14]. Moreover, the surface reactivity of metals is useful for dental applications [18]. 
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Unlike metals and ceramics, it is difficult to generalize the properties and behaviors of polymers, as this 
class of materials is large and diverse. The common definition that holds them together is that polymers are 
large macromolecules that are comprised of repeated monomer sequences, most commonly with covalent 
bonding between monomers [8]. Polymers have a broad range of uses; a few common examples are for food 
and water packaging [19] and for textiles [20]. Due to the broad definition and range of potential applications of 
polymers, they are further categorized as either natural or synthetic. Synthetic polymers are derived from 
petroleum and created in a laboratory setting by monomer synthesis and polymerization of the monomers [21] 
and natural polymers (or biopolymers) are extracted from natural resources (biosynthesized) or can be 
synthesized in a laboratory, and may self-assemble or may require moderators for polymerization [22]. Examples 
of synthetic polymers are plastics, and examples of biopolymers are polypeptides, polysaccharides, and 
polynucleotides. One key difference between common synthetic and natural polymers is that most natural 
polymers readily degrade and synthetic polymers are nearly non-degradable, although there is significant 
research in the field of biodegradable polymers [23]. For biomedical engineering, polymers are used for 
disposable, sterile parts (e.g. IV bags) [24], in implants that replace the function of normal tissue (e.g. hip 
implants, stents) [25] and as biomaterials for tissue engineering [26].  
For the purpose of this dissertation, it is important to consider which specific materials from these 
classes can be used as biomaterials and why. Although a few examples were given for biomedical applications 
of each material class, not every example listed would actually be considered an example of a “biomaterial”. 
Although the definition has evolved since then, as stated in one of my co-authored reviews [27], “a biomaterial 
was defined by the National Institutes of Health in the 1980’s as ‘any substance (other than a drug) or 
combination of substances, synthetic or natural in origin, which can be used for any period of time, as a whole or 
as a part of a system which treats, augments, or replaces any tissue, organ, or function of the body’ [28]”. 
Therefore, in order to design biomaterials, it is necessary to understand the cellular and molecular level factors 
that underlie healthy human physiology. 
 
1.1.1 Our muse for biomaterial design: The extracellular matrix (ECM) 
 
As stated in the previous section, the ECM is the biopolymer network (matrix) surrounding cells (extracellular) 
which provides mechanical support, biological cues and many other functions to the tissue [7]. The function of 
ECM depends on the macromolecules that it is comprised of; for example, collagen type I provides important 
structural support for both cells and the tissue as a whole, and therefore the ECM of load-bearing tissues are rich 
in collagen type I [29]. Collagen is a fibrillar protein comprised of three protein chains wound to form a triple 
helix. There are nearly 30 identified forms of collagen, however the five most common types are type I (skin, 
bone, tendon, vasculature), type II (cartilage), type III (co-expressed with type I in reticular fibers), type IV (basal 
lamina) and type V (placenta). Most of these collagen types will form fibrils and fibers by parallel arrangement of 
the tropocollagens (the tightly wound triple helix of collagen chains). However, there are a few collagens, such 
as collagen IV, which form a looser triple helix, and link head-to-head instead of parallel [30]. Depending on the 
collagen, there are many cell-binding or molecule-binding sites. Collagen I for example has binding sites for 
calcium phosphate (biomineralization) [31], integrin recognitions sites for integrins α1β1 and α2β1 [32], and 
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fibronectin [33]. Excessive and disorganized production of collagen leads to poor mechanical properties of 
tissues, and is characteristic of fibrotic scar tissue formation [34]. Although essential, collagen alone is not  
sufficient to provide all structural functions of ECM, in particular due to its high stiffness. Elastin is a hydrophobic, 
highly stretchable protein that is highly important for recovering the shape of certain tissues after deforming 
them, and is abundant in skin, tendon or ear cartilage [35]. The elastin precursors, tropoelastin, include 
alternating blocks of hydrophilic and hydrophobic residues. Although not ascertained, most believe that elastin 
has high mechanical toughness due to large, aggregated elastin molecules (hydrophobic components) being 
surrounded by a loose, amorphous phase (hydrophilic components). When elastin is stretched, hydrophobic 
regions are exposed, and these regions impose constraints upon water molecules. When tension is released, 
the released energy from the more ordered system drives the elastin to recoil back to its original shape. Without 
elastin, or with poor production of elastin, skin hangs from skeletal muscle (cutis laxa) [36] and arteries can be 
overly stiff [37]. Another important ECM molecule for resisting mechanical forces is hyaluronic acid. Hyaluronic 
acid is an anionic, non-sulfated glycosaminoglycan that can bind a large quantity of water molecules [38]. For 
this reason, it is an important ECM molecule in skin, cartilage and muscle. The biological activity of hyaluronic 
acid depends on its molecular weight, where low molecular weights promote angiogenesis and result in 
inflammation, and high molecular weights repress angiogenesis and reduce inflammation. Cells recognize 
hylaruonic acid with the cell-surface protein CD44 [39, 40]. Excess production of hyaluronic acid is common for 
inflamed tissues and when found in tumor or cancer tissue is a sign of poor prognosis. Although structural 
proteins are of utmost significance to healthy tissues, proper cell adhesion, coordination, and ECM matrix 
formation are also critical, and mediated by proteins such as fibronectin.  
Fibronectin is a protein that contains binding sites for heparin, collagen type I, fibrin and cell integrins, 
and is in particular “famous” for the cell-recognition peptide sequence Arginine-Glycine-Aspartic Acid (RGD) 
(PubChem CID: 104802) [41, 42]. The discovery of RGD in fibronectin was a great step in understand binding of 
cells to ECM due to the ubiquitous recognition of different integrin classes to RGD [43]. Fibronectin is also a 
mediator between collagen IV and laminin in the basal lamina [44]. Therefore, fibronectin play a major role in 
building organized ECM and mediating cell-ECM interactions, Figure 3. For example, it was discovered that 
knockout of fibronectin is embryonic-lethal in mice [45]. Fibronectin is also found in a soluble form in the blood 
stream, and thereby performs important functions for blood clotting and wound healing, as can be inferred from 
its binding activity to fibrin and fibroblasts [46]. 
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Figure 3: The molecular organization of ECM and cell -ECM interactions. A fibroblast 
(represented by the green ell ipsoidal shape) responds to its surrounding and can alter its 
surrounding ECM. The classic organizat ion of collagen, proteoglycans and fibronectin is also 
shown. Reprinted from The American Journal of Pathology, 184Thannickal, V. J., Henke, C. A., 
Horowitz, J. C., Noble, P. W., Roman, J., Sime, P. J., Zhou, Y., Wells, R. G., White, E. S., 
Tschumperlin, D. J., Matrix Biology of Idiopathic Pulmonary Fibrosis, 1643-1651., 2014 with 
permission from Elsevier; this  article is published under the terms of the Creative Commons 
Attribution-NonCommercial-No Derivatives License (CC BY NC ND) [47]. 
 
When designing biomaterials, the most obvious approach would be to extract this ECM from donors and use it 
directly, or to try to engineer exacts mimics. However, there are two major problems to doing this.  
 
(1) Source: Although it is possible to access and isolate human ECM, the number of donors is limited, 
and, depending on the ECM molecule, the yield is low, and there is possibility for batch-to-batch 
variation. Therefore, for the purpose of biomaterials engineering and design, it is rare that ECM is 
isolated from human tissue. Instead it is either isolated from an animal source which is available in larger 
quantities (e.g. bovine skin), a biopolymer with similar characteristics (e.g. alginate, synthetic polymers) 
is used instead of the native ECM or it is produce using biotechnology (e.g. recombinant collagen).  
 
(2) Biology: The ECM found in the body is in homeostasis, in particular from mature donors, or, worse, 
in a pathological state. Therefore, the native ECM does not necessarily have the same types of cues that 
will promote tissue regeneration [48]. Engineers must design their biomaterials in order to promote cell 
behavior and thereby tissue regeneration.  
 
By recapitulating key characteristics of the material, biomaterials can be engineered instead of being isolated 
from human tissue and used directly, Table 1.  
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Table 1: Natural ECM molecules, biomolecule type and the tissues containing them.  
ECM Biomolecule Type Key characteristics or functions Tissues 
collagen type I 
 
protein the most abundant protein in the 
human body; fibrillar collagen; contains 
several binding sequences (cell 
binding, protein binding, and mineral 
binding)  
connective (bone) 
epithelial (dermis) 
muscle (heart) 
elastin  protein highly elastic; resistant to permanent 
deformation 
connective 
epithelial (arteries) 
fibronectin  glycoprotein ECM molecular organization; contains 
the RGD sequence; exists in a soluble 
form in the bloodstream (blood clotting)  
connective 
epithelial (basal lamina) 
muscle 
nervous 
hyaluronic acid 
(hyaluronan, HA)  
glycosaminoglycan 
(GAG) 
Absorbs large quantities of water connective (cartilage) 
epithelial (skin) 
muscle 
nervous (brain) 
 
Table 1 should not be considered an exhaustive list of all molecules in the matrisome [49]. The table is missing 
many main ECM components such as laminin (forms the basal lamina of the basement membrane), heparan 
sulfate (found in nearly all tissues), chondroitin sulfate, keratin sulfate, tenascins, only one of twenty-nine types 
of collagen are listed, and vitronectin (glycoprotein important for cell attachment and homeostasis). It also 
contains the RGD cell-binding sequence, and is in particular known for binding to integrin αvβ3, found primarily in 
platelets. Further, this table does not include non-ECM proteins such as fibrinogen, or nucleic acid-based 
materials such as DNA or RNA, which are also sometimes utilized as biomaterials. Instead, Table 1 provides a 
helpful guide for some ECM molecules that are common templates for engineering biomaterials. 
 
1.1.2 Biomaterial selection and design 
 
Engineering design begins by creating a list of requirements and corresponding specifications, as well as 
weighing the relative importance of each requirement. Based on the “req-spec” chart, possible design features 
and materials can be selected. Biomaterial selection begins in a similar manner; however, the relative weight of 
importance of each requirement is different for biomedical engineering than it is for traditional engineering (e.g. 
mechanical or electrical engineering). For example, in traditional engineering cost assessment is usually a high 
priority requirement, however, in designing biomaterials cost is usually a low priority factor due to the fact that 
tissue engineering has a low manufacturing readiness as well as the high cost associated with medical products 
and research [50]. Instead, usually the first question that a researcher should ask is if the material is toxic.  
Material toxicity is evaluated in vitro by incubating cells on biomaterial or with biomaterial in the 
supernatant followed by a method of evaluation such as cell staining or colorimetric assays. Some biomaterials 
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are non-toxic when they are intact, however become toxic when they are degraded. For this reason, the toxicity 
of degraded products should be tested, and it should also be determined at what concentration they are toxic. 
Related to this, it should be evaluated if the degraded products have a tendency to sequester in one place; that 
is, what is the biodistrubtion of the degraded products. Biodistribution is evaluated in vivo where an animal 
model, typically a small rodent, is administered a drug or biomaterial. The distribution of the different 
components is either monitored live by optical methods [51] or by monitoring blood concentration levels for 
clearance rate [52]. After a specified period of time, the animal is sacrificed and relevant tissues (e.g. injection 
site, liver) are examined for presence of the biomaterial [53]. If the biomaterial meets this basic requirements, 
more specialized functions such as inducing certain biological or physiological behaviors can be considered, 
Table 2.  
 
Table 2: Generalized requirements and specifications for tissue engineered scaffolds, and the 
design elements that could possibly be used to meet the requirement.  
requirement specification design elements 
carry or transmit 
force 
1. specific Young’s modulus  
2. specific elastic/plastic behavior (e.g. Creep) 
biomaterial, scaffold morphology 
a certain biological 
function  
1. gene expression and stability 
2. single cell morphology and function  
3. complex, coordinated cell function (tissue or 
organ function, e.g., muscle contraction) 
cell type and source, biomaterial, 
scaffold morphology   
biocompatible  1. low immunogenicity  
2. no toxicity  
3. no toxicity of degradation products  
biomaterial, removal of 
processing residues (e.g. emulsion 
oils, crosslinking reagents)  
sterile  1. must be free of all contaminants (bacteria, 
viruses, endotoxins or PAMPs) 
processing technique, biomaterial 
(tolerates sterilization techniques)  
specialized functions  
(light/electricity/sound 
transmission) 
1. opacity, conductivity, mechanical stiffness; 
depends on the desired function  
cell type and source, biomaterial, 
scaffold morphology  
 
To summarize, a biomaterial should be selected based-on desired physical (optical/electrical), chemical, 
physiochemical (hydrophobicity), biochemical, mechanical and biological properties. Important 
biological properties include its biocompatibility, its immunogenicity, and its toxicity. Further, the 
suitable morphology must be considered as well, as how the morphology is generated is partially 
determined by the selected biomaterial. Overall, different material classes have different benefits based upon 
these basic requirements, however, as inducing certain biological/physiological responses is such an important 
feature to a biomaterial, metals or ceramics are rarely considered in the material selection process, [54]. A few 
exceptions, especially for bone tissue engineering, are titanium oxide, bone graft paste and bioglass [55]. These 
types of materials tend to be more popular in industry due to their more predictable behavior, practicality 
(fabrication, storage, sterilization) and cost-effectiveness. Implants produced from these types of materials (e.g. 
hip implants) can significantly improve the quality of a patient’s life; however, they also have many drawbacks. 
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For example, most hip implants have to be replaced after 15-20 years, or, worse, there can be a critical failure of 
the implant due to breakage at the bone-implant interface or debris production at the artificial joint [56]. In the 
academic sphere, the use of metals and ceramics has significantly diminished, and most researchers 
concentrate on developing polymer-based implants.  
Common synthetic polymers used as biomaterials are poly(caprolactone) (PCL) [57, 58], poly(lactic acid) 
(PLA) [59], poly(glycolic acid) (PGA) [60], poly(lactic-co-lycolide) (PLGA) [61, 62], ultra-high molecular weight 
polyethylene (UHMWPE) [63] and PEG-based (PEO-based) polymers and derivatives [64-66]. PLA is a unique 
synthetic polymer in that it is produced from renewable resources. PLA is also a popular biomaterial due to 
adhesion of cells and slow degradation by hydrolysis. In contrast, PGA degrades rapidly and in bulk by 
hydrolysis, however, its monomers are absorbable, whereas the degradation product of PLA (lactic acid) have 
acute toxicity. Therefore, to tailor both the degradation and decrease the potential toxicity of the PLA, the block 
co-polymer PGLA was developed. PGLA also exhibits erosion due to hydrolysis of the ester bond; however, this 
can be adjusted based upon the amount and sequence of the monomers. Nevertheless, in terms of polymers 
that degrade by hydrolysis, PCL has the slowest rate of biodegradation and is therefore especially well-suited for 
drug delivery. Further, PCL has been shown to promote collagen synthesis by mammalian cells, and is therefore 
appropriate for scaffolds for tissue engineering. Conversely, UHMWPE is rarely used for tissue engineering; 
however, due to its strength as well as low-friction properties is a popular choice for the surface of the joint for 
hip implants. PEG/PEO are one of the first biomaterials to be implemented; proteins do not readily adsorb to 
PEG, and they are biologically inert and nontoxic. PEG can be used as-is for drug delivery, or is an excellent 
platform to modify for special applications. For example, PEG can be produced as crosslinkers, block co-
polymers, grafted with other polymers, or blended with other synthetic or natural polymers. 
Of natural polymers, common protein-based biomaterials are collagen (type I or V) [67, 68], gelatin 
(including methylacrated gelatin (GelMA)) [69, 70], Matrigel [71] and silks [27, 72], and common polysaccharide-
based are chitosan [73-75], alginate [76], hyaluronic acid [77-79], Figure 4. 
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Figure 4: A comparison of common natural polymers (biopolymers) used as biomateria ls. The 
general structure is shown, and some key properties are listed. In the top half of the figure, 
proteins collagen, Matrigel and si lks are shown, and in the bottom half polysaccharides alginate, 
chitosan and hyaluronic acid are shown. The chemical st ructures of alginate, chitosan and 
hyaluronic acid are taken from the PubChem database [42].  
 
Collagen-based biomaterials are sourced from rat-tail, bovine skin, or porcine skin, and rarely from humans; 
thereby, the use of native collagen has the risk for immune response or disease transmission [80]. Alternatives to 
using native collagen are gelatin and recombinantly produced gelatin/collagen. Gelatin, essentially a single 
collagen strand, has the advantage that it is far easier and cheaper to extract and produce, and is easier to 
functionalize or manipulate [69]. For example, it can be methylacrated to produce GelMA, which allows for rapid, 
cytocompatible photo-crosslinking. Furthermore, due to its additional production steps, it has nearly no problems 
in terms of antigenicity or sterility [70]. However it has the disadvantage that it can only be produced from 
collagen type I rich tissues, without modification gelatin-based hydrogels are unstable at 37 °C and will undergo 
a sol-gel transition [81]. Recombinant production of gelatin/collagen, on the other hand, is difficult to scale-up 
and, when native-like protein folding is desired, are challenging to develop [80, 82]. However, recombinant 
collagen/gelatin has the distinct advantage that the researcher has fine control over the end-product, as well as 
the ability to make any type of collagen. Another interesting, collagen-rich biomaterial is Matrigel, in particular as 
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it has a high collagen type IV content, as opposed to collagen type I. Matrigel is roughly composed of ~60% 
laminin proteins and ~30% collagen IV proteins, as it is isolated basement membrane from mouse tumors [71]. 
The main advantage of Matrigel is that these proteins, normally difficult to isolate, are easily obtained and 
promote high cell attachment and proliferation. However, due to the imprecise composition of Matrigel (contained 
trapped growth factors) the results achieved with Matrigel are not highly repeatable. Overall, it is clear that there 
are many disadvantages to harvesting ECM from animal sources. There is one ECM macromolecule that is 
commercially produced using biotechnology, hyaluronic acid. Hyaluronic acid is a non-sulfated, anionic 
glycosaminoglycan which is primarily disaccharide repeats of D-glucuronic acid (GlcUA) and N-
acetylglucosamine (GlcNAc). Hyaluronic acid is biologically synthesized in the Gram-positive bacteria 
Streptococcus zooepidemicus [77]. Hyaluronic acid is useful for its high water binding activity, which helps 
sequester growth factors and increase mechanical stability against cyclic loading. A disadvantage is, as stated 
previously, low molecular weight hyaluronic acid causes inflammation, and it is therefore should be considered 
when selecting a molecular weight [78]. Interestingly, accumulation of low molecular weight degradation products 
can promote angiogenesis [79].  
 Although it is reasonable to use the native macromolecules found in the ECM, it is also possible to 
consider alternative sources of biopolymers to reduce the common risks of these molecules such as immune-
rejection, disease transmission and batch-to-batch variations in the biomaterial quality. Therefore, materials such 
as cellulose, agarose, alginate, chitosan, silks, and non-animal collagen can be used. As stated previously, 
particularly popular and interesting biomaterials are alginate, chitosan and silk. Alginate is an anionic 
disaccharide isolated from seaweed (usually brown seaweed) that can have varying amounts of β-D-mannuronic 
(M-block) and α-L-guluronic acid (G-block), which plays an important role in determining its final characteristics 
[76]. Its properties are further determined by its production method. Alginate can be purified by precipitation with 
calcium (calcium alginate), or it can be purified by using an acid to form a gel,  diluting the gel, and then further 
precipitating using sodium carbonate (sodium alginate). Alginate is advantageous in terms of its simple 
production and low antigenicity, however, it contains no native cell binding peptides. This, combined with its 
anionic nature, results in low cell adhesion to alginate. Further, as it is crosslinked by positive ions like calcium, it 
tends to erode in solutions containing cations [83]. Chitosan, on the other hand, is a cationic linear 
polysaccharide comprised of D-glucosamine (randomly acetylated or deacetylated) and sourced from 
exoskeleton of crustaceans [84]. Chitosan has hemostatic properties (can quickly stop blood flow) making it an 
excellent wound dressing. Although it has no cell-binding sites, the positive charge can promote cell attachment 
[73]. The positive charge also allows for complexing to negatively charged nucleic acids, making it favorable for 
gene delivery [74]. Major disadvantages of chitosan are that it is susceptible to seasonal availability and batch-
to-batch variability, it is difficult to adapt the mechanical properties and it tends to be mechanically weak [85]. In 
contrast, silk-based proteins have high mechanical strength and toughness, and depending on the type of silk, 
how this silk is processed, or if the silk is crosslinked, several types of mechanical behaviors can be obtained 
[72, 86]. Silk proteins are glycine-rich polypeptides usually sourced from the cocoons of Bombyx mori silkworms. 
Different types of silk fibroins are defined primarily by differences in their repetitive core domain, and their non-
repetitive termini. The mechanical toughness of silks is attributed to the combination of strong, highly ordered 
beta sheet crystals embedded in an amorphous, alpha-coil and coil-coil phase. Further, due to a lack of enzyme 
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recognition sites and resistance to hydrolysis, silks have slow biodegradation, and are particularly well-suited for 
applications that require slow biodegradation [87, 88]. The main disadvantage of silks is that they have also no 
cell binding peptides, with a few exceptions, and usually has a negative charge, leading to low cell adhesion 
[27]. Further, silk obtained from natural sources is also susceptible to variations.  
 As made apparent throughout this discussion, many common biomaterials have both advantages and 
disadvantages. Therefore, in order to overcome these disadvantages, or increase the number of advantages, 
novel biomaterials have to be produced. This can include creating biomaterial hybrids [75], functionalization of 
biomaterials with chemical reactive sites (e.g. for photo-crosslinking [89]) or biologically active sites (e.g. RGD 
[90]), or by developing new materials.  
 
1.2 Recombinant spider silk protein  
 
1.2.1 Biotechnological production 
 
Spider silks are highly versatile materials that are used as a textiles or textile coatings [91, 92], for cosmetic 
products [93] and for biomedical products [27]. However, producing all of these spider silk-based products with 
natural spider silk would be difficult and time-consuming. Farming spiders requires a lot of space due to their 
cannibalistic behavior, and the amount of silk that can be harvested from each spider is low. Therefore, 
biotechnology is used to produce recombinant spider silk protein, or engineered spider silk protein, Figure 5. 
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Figure 5: Biotechnological product ion of recombinant spider si lk proteins based on ADF -4 (C 
module proteins, blue) and ADF-3 (A and Q module proteins, green and orange). (A) Derivation 
of the engineered sequence based on the natural sequence and translation to E. Coli codons (B) 
Insertion of consensus sequence using restricted insertion sites (C) Demonstrates the flexibi li ty 
of the recombinant production; full -length or partial-length synthetic proteins, or different 
patterns of the modules, can be generated for better understanding  of spider si lk. Reprinted 
from Microbial Factories, 3, Schiebel, T., Spider silks: recombinant synthesis, assembly, 
spinning, and engineering of synthetic proteins,  2004 with permission from BioMed Central Ltd.  
[94]; this is an Open Access article distributed under the terms of the Creative Commons 
Attribution License.  
 
To produce recombinant spider silk it was first necessary to determine the DNA sequence that encodes the 
protein, normally this requires extraction of the silk producing gland, followed by purification of the mRNA and 
conversion into complementary DNA (cDNA). For this reason, recombinant spider silk proteins are usually 
based-on a specific spider, type of silk, and protein. The silk genes are identified from their 5’ or 3’ ends, and the 
different DNA fragments (cDNA library) are then compared against a database of known, whole genome 
14 
 
sequences and mass spectrometry patterns obtained from enzymatically digested silk proteins found in silk 
glands. Subsequently, consensus sequences can be derived from the newly identified protein [95]. Once the 
natural DNA sequence is determined, a synthetic DNA can be created based on mimicking important properties 
of the desired product.  
In spider silk, repetitive sequences found in the proteins core domain are critical for the functionality of 
spider silk protein within the fiber, and their secondary structures within the fiber are in turn responsible for their 
mechanical strength and stability. Due to host-determined limitations for producing large proteins, the natural 
sequence must be shortened and simplified. Therefore, to imitate the key properties of spider silks, the 
consensus sequence is determined, that is, most commonly found repetitive amino acid blocks are determined. 
The consensus sequence is then used as the template for designing the engineered consensus module.  
In addition to the core domain, artificial constructs also often include the design for the highly conserved 
terminal domains, which are critical for the stabilization of the highly concentrated proteins in the gland and the 
alignment of the protein chains along fiber formation [96, 97]. The gene design method further allows for 
introducing specific functionalities that do not necessarily have to be derived from silk, such as cell binding motifs 
or biomineralization domains or domains from other structural proteins such as elastin.  
The next step of recombinant protein production is to build a vector, a vehicle designed to deliver recombinant 
DNA. Normally vectors are plasmids, circular structures that contain the DNA sequence with other necessary 
components. This means that they are able to replicate independently from chromosomes, which gives them an 
advantage in terms of their simplicity. Plasmids include the recombinant DNA itself, an “instruction” for how many 
times the plasmid should be copied (a replicon), a promoter gene to turn expression on, a sequence encoding 
an affinity tag for purification and one encoding a cleavage site, which allows for removal of the affinity tag, and a 
gene encoding antibiotic-resistance for selecting properly expressing colonies (a selection marker) [98]. The 
plasmid is selected and the synthetic gene designed, expression vectors are first created and replicated by 
expansion of positively expression colonies, primarily in Escherichia coli (E. coli) [98-100].  Plasmids are then 
extracted and transduced into the host for final production of the recombinant protein. For unicellular (prokaryote 
and eukaryote) systems this is most commonly done by heat shock, which makes the host vulnerable to foreign 
DNA. Based on limitations or strengths of a host, the recombinant DNA or the plasmid may have to be re-
designed if there is improper production of the recombinant protein. Then the transfected host culture is allowed 
to expand, protein expression is transduced and then later the host cells are lysed and the proteins purified.  
 
1.2.2 Recombinant spider silk protein eADF4(C16)-based biomaterials  
 
Recombinant spider silk engineered Araneus diadematus fibroin 4 with 16 repeat C-module (eADF4(C16)) is, 
much like other silks, an anionic biopolymer with no native attachment sites for cells [101-103]. However, 
eADF4(C16) outperforms most other silks (and biopolymers) in terms of its toughness [104] and low 
immunogenicity [105]. Further, eADF4(C16)-based materials are biocompatible [103, 105] and have slow 
biodegradation [88, 106], Figure 6.  
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Figure 6: Key properties of recombinant spider silk eADF4(C16) as a biomaterial and 
corresponding citations where each property was evaluated and determined. Partially adopted 
from Biotechnology and Applied Biochemistry, 55, A. Leal -Egana, T. Scheibel, Si lk-based 
materials for biomedical applicat ions, 155-167, 2010, with permission from John Wiley and Sons 
[107]. 
 
Unmodified eADF4(C16) does not promote cell adhesion, which, although useful when trying to “cloak” implants 
from an immune response [105, 106], is typically an undesirable trait. However, due to the biotechnical 
production of this protein, it is simple to modify the protein to promote basic cell behavior such as attachment, 
spreading and proliferation. Variants of the recombinant spider silk protein eADF4(C16) which promote these cell 
behaviors include eADF4(C16)-RGD and, for some cell types, eADF4(ĸ16). eADF4(C16)-RGD contains the 
RGD peptide sequence at the C-terminal end of the eADF4(C16) protein. This simple addition was shown to 
increase cell attachment from 75 % to 120 % (normalized to attachment on cell culture plate), as well as promote 
cell proliferation [103]. eADF4(ĸ16), on the other hand, can promote cell adhesion, depending on the cell type, 
by changing the physical properties of the protein by switching glutamic acid (E) residue with lysine (K), resulting 
in a net positive charge (eADF4(C16) has a net negative charge) [108]. An alternative method to promoting cell 
attachment onto eADF4(C16) is by changing the topography, for example to channels [109] or to nonwovens 
[110]. 
 
16 
 
1.3 Scaffold design  
 
1.3.1 Scaffold design in tissue engineering  
 
After a material is selected, it has to be processed into a specific morphology that will essentially be the 
scaffolding of the final tissue engineered product. The most common morphologies used in tissue engineering 
are films, foams, nanofiber meshes and hydrogels. Other common morphologies in regenerative medicine are 
fibers and particles, which can be used for suturing/weaving or drug delivery, respectively, Figure 7. 
 
 
Figure 7: Scaffold morphologies used in regenerative medicine. Partial ly adopted from Advanced 
Materials, 30, Aigner T., DeSimone E. and Scheibel T., Biomedical Applications of Recombinant 
Silk-Based Materials, 28, 2018, with permission from John Wiley  and Sons [27]. 
 
The different morphologies shown in Figure 7 are achieved by using different processing techniques. Particles 
and capsules are usually produced by either mixing solution, creating an emulsion in solution, using microfluidics 
[111] or by emulsion/salting-out [112]. Particles are particularly useful for drug and gene delivery [113], or to 
modify the mechanical properties of another scaffold type (e.g. particle-reinforced hydrogels) [114]. Fibers in the 
range of micrometers are usually produced by wet-spinning or microfluidics, or can be isolated directly from 
tissue or silkworm silk cocoons, and are useful for producing nerve-grafts, vascular grafts, or tendon-
replacements [115-117]. Fibers in the range of nanometers are usually produced by electrospinning for wound 
dressings, 2D cell culture and tissue engineering membrane tissues such cornea [118-120]. Films are produced 
using solution casting, dip coating, spin-coating for 2D cell culture, drug delivery and implant coatings [121, 122]. 
Foams are produced by cyrogelling, salt leaching, and freeze-drying and are advantageous for their resistance 
to compression and are utilized for bone tissue engineering or as additional mechanical support in composite 
scaffolds [123]. Hydrogels are produced by crosslinking a low concentration polymer solution, and are commonly 
used for fillers, 3D cell culture and drug delivery depots [124].  
Generally, a particular morphology is selected based upon the application. For example, flat films would 
not be used to create a large 3D tissue such as muscle, but can be useful for thin tissues or membranes such as 
skin or cornea. However, certain morphologies tend to be more widely applicable than others; in particular, 
hydrogels can be used for almost any application, given that they are made mechanically stable either by 
maturation with cells in vitro or by being prepared as a composite with a more mechanically stable morphology 
like nanofibers or foams.  
As hydrogels and nanofibers are the morphologies that were used for the work presented in this 
dissertation they will be discussed in greater detail.  
 
17 
 
1.3.2 Electrospinning  
 
Electrospinning is the production of micro/nanofibers by applying a driving voltage to a slowly moving jet towards 
a collector, which usually has a voltage of the opposite charge. Ideally, generating this electrical field leads the 
formation of a Taylor cone, from which a jet should originate. This jet will undergo whipping instabilities, and this 
draws out the fiber to the point where the diameter is on the micro to nano-scale. Key parameters in 
electrospinning include solution concentration, solvent used, flow rate, needle length and diameter, driving 
voltage, working distance, collector voltage, collector geometry and substrate, air humidity, and the use of other 
design features such as insulation elements [125]. As an example, the set-up for the device used for this 
dissertation is shown, as well as key parameters that relate to electrospinning the solution, Figure 8. 
 
 
Figure 8: The electrospinning process. A syringe is driven at a particular speed (F) and a high 
voltage difference is applied between the capil lary tip and the collector plate, which are kept a 
certain distance apart (h), producing a nonwoven mesh. Translated from the dissertation of 
Gregor Lang, Herstellung und Charakterisierung von Fasern aus rekombinanten 
Spinnenseidenproteinen und deren potentielle Applikationen , University Bayreuth under the 
terms of the CC-BY 3 license [126].  
 
Although the idea of forming fibers from ‘whipping instabilities’ sounds chaotic, by fine-tuning the mentioned 
parameters the fiber mat production can be significantly controlled. For example, different fiber diameters can be 
produced by changing solution concentration [127], or aligned fibers or patterned fibers can be produced by 
patterning the electrical field through use of insulation elements, aligned electrodes or a rotating mandrel [128]. 
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Nonwoven as well as aligned fiber mats are most commonly characterized by SEM and then further analyzed for 
fiber diameter distribution and degree of alignment [129]. Determining the mechanical properties of nonwovens 
is complicated due to the different scales (nano-sized fibers, millimeter sized mats), as well as the potential 
effect of pre-tension existing in the fibers before measurement. The most common methods used are atomic 
force microscopy (AFM) or nanoindentation to measure the nanoscale properties, and tensile testing of a yarn 
formed of the mat for the macroscale properties [130, 131].  
 
1.3.3 Hydrogels  
 
Hydrogels, by their simplest definition, are low concentration polymer networks containing high percentages of 
water. Hydrogels are fabricated by crosslinking a low concentration polymer solution; methods of crosslinking 
can be physical (e.g. temperature) or chemical [124], Figure 9. Crosslinkers can either be added directly into the 
hydrogel precursor solution, or the hydrogel precursor solution can be dipped in or sprayed with crosslinker. In 
case of the latter, it is important to differentiate between forming a hydrogel, a coagulated fiber or a film. 
 
 
Figure 9: A generalized figure for crosslinking hydrogels and the typical properties of the 
polymer network. Physically crosslinked synthetic polymers (with the exception of co -block 
polymers) hydrogels are not common, and therefore indicated by dashed arrow.  
 
Important properties of hydrogels to fabricate suitable scaffolds important parameters to consider include 
gelation rate, swelling, stiffness, porosity (mesh size), biodegradation as well as the functional response of cells 
to the biomaterial itself. Mesh size and degree of swelling can determine how well the hydrogel permits nutrient 
and waste exchange, as well as the mechanical stiffness of the hydrogels. Swelling is usually one of the simplest 
characteristics to observe, and is done by recording changes in weight or size before and after incubation in 
buffer [132]. Mesh size is most commonly determined by tracking the diffusion of different molecular weight 
markers through the hydrogel [132]. The degradation rate is significant parameter, and should be tailored such 
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that the rate of tissue regeneration and the rate of degradation matches perfectly. Degradation can be monitored 
by changes in weight, size, or measuring soluble polymer or protein or drug found in the supernatant, however 
there are other methods such as imaging or changes in stiffness that can be used [133]. Mechanical stiffness 
itself playing a significant role as this can determine stem cell fate and differentiation, or significantly change cell 
behavior. Stiffness of hydrogels is measured using rheology [134], or by compression testing [132].  
 
Achieving a functional cell response by controlling variables in scaffold processing is a complicated issue, due to 
limited understanding of the biological mechanisms behind regeneration, but also due to the crude techniques 
used to generate the different morphologies. These methods can result in residues of cytotoxic chemical 
crosslinking agents, inhomogeneous cell distribution, no control over cell position and poor nutrient/waste 
exchange in scaffold bulk (for large, 3D constructs). Therefore, there has been a strong movement to make 
scaffold processing more cell-friendly, and to enhance control over scaffold generation.  
 
1.4 Biofabrication  
 
The term biofabrication has been around since 1994, where it was first used to describe biomineralization. Since 
then it has been used by many different fields, many of which have their own definition [135]. Within biomedical 
engineering, it was first used in 2004 to describe the use of biological materials or catalysts to aid in 
microfabrication. For example, using microorganisms to create nano-structure surfaces [136]. The most well-
accepted use of the term today is the fabrication of materials by living organisms [135]. For the tissue 
engineering community, this term is used to categorize techniques where scaffolds are produced with a relatively 
short fabrication time and high precision, normally in the presence of living cells. These types of techniques have 
been used for years, for example, 3D bioprinting has publications dating back 15 years; however, the use of this 
term is increasing due to the increasing number of publications and interest within this field. Due to this 
complicated past and parallel use [137], the term “biofabrication” is confusing and often misused. A few attempts 
have been made to made a universal definition of biofabrication, that is, a term that is used by all fields of 
discipline, however the lack of consensus is likely to continue if the community continues to write independent 
reviews instead of meeting, for example at a conference, where terms such as biomaterials and tissue 
engineering were defined.  
Due to these many complications, a clear definition of biofabrication that will be used for this dissertation 
is as follows: Biofabrication is the simultaneous processing of biomaterials and biological materials to 
create constructs with a biological function. Examples of biofabrication techniques include simple 3D cell 
encapsulation, modified 3D cell encapsulation using microfluidics or force-driven (e.g. dielectrophoresis-driven, 
magnetic-driven), biospraying, electrospinning with bioactive compounds and 3D bioprinting, Figure 10.  
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Figure 10: Generalizations of common biofabrication techniques including cell encapsulation by 
simple gelation, magnetic or electrically -dr iven positioning of cells in the matrix before 
encapsulation, and microfluidic-flow to produce fibers or beads before encapsulat ion. Cells 
suspended in matrix or in solution can also be delivered or patterned using biospraying, 
electrospinning or 3D bioprinting.  
 
Cell encapsulation refers to the process where cells are suspended in a biomaterial solution followed by 
crosslinking of the solution to produce a hydrogel. Cells encapsulated in matrix are referred to generally as 3D 
cell culture systems; however, when they are used for 3D bioprinting they are termed bioinks [138, 139]. Cell 
encapsulation itself results in uncontrolled cell location, and therefore more novel biofabrication techniques 
include driving the cells to a particular position using similar principles to dielectrophoresis, or by driving in a 
magnetic field. This technique has therefore been used to pattern cells in a 3D medium and promote cell-cell 
interactions, one great advantage of this technique [140]. However, this technique tends to be limited in the z-
direction, and therefore does not allow for the production of thick structures. Microfluidics can be used to 
encapsulate single cells or to produce complex composite materials. For example, single cells could be 
encapsulated with antibody capture beads, and could thereby be sorted and analyzed for antibody production 
[141]. The disadvantage to microfluidics is that, although it is relatively simple to scale-up to mass production, 
the produced scaffolds are too small to be used directly as a tissue replacement, and therefore the components 
have to be further assembled after production. Alternatively, there is bio-electrospraying, which can deliver a high 
number of cells to a large surface areas directly in situ. However, the resulting structures are 2D and not 3D, and 
therefore have limited use to spraying on top of scaffolds or into wound sites. 3D bioprinting, one of the most 
promising techniques in biofabrication, is the 3D assembly of bioinks into large 3D constructs. Although this 
technique can certainly be improved, most agree that the 3D bioprinters themselves are quite advanced, and 
that the main challenge behind producing 3D bioprinted scaffolds is the manufacture of novel biomaterials 
suitable for biofabrication.  
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1.4.1 Biomaterials for biofabrication  
 
As implied, developing materials for biofabrication imposes additional requirements on the biomaterial that were 
outlined previously in Table 2. Some of these additional requirements for biofabrication are general, such as all 
crosslinking processes must be non-cytotoxic. Others are process-dependent restrictions, for example, material 
used for microfluidics must undergo a sol-gel transition within seconds or minutes. Cell encapsulation in a 
hydrogel, on the other hand, may take a few hours without reduction in the cell viability. In the case of bioinks, it 
depends on the desired behavior; if the bioink is crosslinked before printing, the crosslinking process can take a 
few hours, whereas if the bioink is crosslinked post-printing, it must occur within seconds or minutes. Choosing 
between these two modes of crosslinking, before or after printing, will further have different advantages in terms 
of its printability.  
 For a bioink to be printable, it must be injectable, in other words, it must yield under process-relevant 
conditions. Yield stress of a material has many forms of evaluation, but two common methods are rheology 
(strain sweep) and by measuring the force required to eject the hydrogel from a syringe [142]. If it meets this 
basic requirement, then the material can then evaluated for its “printability”. Printability refers to the quality of the 
fiber formation, the printing resolution and the shape fidelity [143, 144], Figure 11. Fiber formation refers to the 
stream of material that appears after actuation, and the important characteristics include the tendency of the 
material to stress-relax at the tip and the flow rate. Printing resolution is usually defined as the diameter of the 
printed strand. Shape fidelity refers to the tendency to hold the form of the printed fiber under the forces of 
gravity. 
 
 
Figure 11: Characteristics of a bioink to determine its printability: f iber formation, resolution and 
shape fidelity. “High” on the scale indicates that this indicates high printability, and vice verso 
for “low” on the scale.  
 
To understand the mechanisms which underlie printability, it is also important to clarify the dynamic mechanical 
behavior (shear-dependent behavior) of the material, which underlies its printability. These are usually evaluated 
using rheology, for example, by a shear-thinning test. In order to avoid needle clogging, however also have high 
shape-fidelity, it is necessary for a material to have a high viscosity at low shear-rates, and a low viscosity at high 
shear rates [143]. Refer to section 1.4.3 and Figure 14 for more details.  
Combining the characteristics of an excellent 3D culture system and a highly printable material is further 
complicated by the interaction between these two characteristics. For example, to have high shape fidelity 
usually a high elastic modulus is required, which usually translates as a dense biopolymer mesh [132]. A dense 
22 
 
mesh, however, is usually not beneficial for 3D cell culture due to limited nutrient/waste diffusion; it is more 
difficult for cells to proliferate, and it limits the ability to tune the biomaterial stiffness to the desired differentiation 
path of the cells. Therefore, novel materials for bioinks should have low mesh density combined with high 
stability [138].  
Common bioinks thar are particularly promising are produced from alginate, GelMA, modified hyaluronic 
acid (for rapid polymerization), PEG and PEG-derivatives (e.g. 8-arm PEG, Pluronic), blends with gelatin, blends 
with hyaluronic acid and blends with PEG or PEG crosslinkers [138, 139, 145]. Although less well-studied, 
peptide-based or recombinant protein-based hydrogels, such as recombinant spider silk protein, are alternatives 
to the more common bioinks. For example, a short peptide-based biomaterial could form mechanically stable 
hydrogels at low concentrations (5 mg/mL to 10 mg/mL) and there was cell spreading after two weeks [146]. 
GelMA, on the other hand, generally does not form stable gels at such low concentrations; however has great 
flexibility in terms of tuning its mechanical properties through changes in the concentration of GelMA, 
concentration of crosslinker, and crosslinking time [147]. Overall, in order to maintain the advantages of different 
bioinks and minimize the disadvantages, further materials must be engineered and studied, and likely, these 
materials will have to be used in combination either by synthesizing new biomaterials or by creating composites, 
for example by blending. Once a printable bioink is developed, other key outcomes such as maximum building 
volume and the fabrication time can be determined, which is also effected by the printer that is utilized. 
 
1.4.2 3D bioprinting 
 
3D bioprinting is the most popular biofabrication technique due to its short fabrication times, precision and the 
wide availability of commercial 3D bioprinters [137]. The most common types of 3D bioprinters are laser-
assisted, extrusion-based, and inkjet, Figure 12  
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Figure 12: Types of 3D printers and their modes of actuation, the materials that can be pr inted 
based on their viscosity, and the type printed structure. Reproduced with minor corrections from 
Pure and Applied Chemistry, 87, DeSimone E, Schacht K. and Scheibel T., Biofabrication of 3D 
constructs: fabrication technologies and spider silk proteins as bioinks , 1-13, 2015, with 
permission from De Gruyter [139]. 
 
Extrusion bioprinting is the application of pneumatically or mechanically-drive pistons or screws to dispense 
fibers. This method is advantageous in its simplicity, short fabrication time and breadth of compatible materials. It 
is disadvantageous in terms of its low precision compared to the other printing modes [138]. Inkjet printing is 
useful for printing low viscosity, or cell-only solutions, with a micrometer resolution, however, cannot print high 
viscosity hydrogels and thick constructs [148]. Laser-induced transfer printing (LIFT) has similar advantages and 
disadvantages to inkjet printing; a few distinctions include that the cell viability is much higher, however, the set-
up is much more complicated and the fabrication time is longer [148, 149]. Inspired by LIFT, there are also 
methods that use a similar approach to stereolithography, where laser energy and masks are used to create 
hydrogel patterns into a layer of solution [150]. This allows for generating larger constructs, but again is more 
limited in terms of types of bioinks that can be used. Although each method of 3D bioprinting has its advantages 
and disadvantages, most will use either inkjet or extrusion-based bioprinting; there is a greater variety of printers 
available, and they are less limited in terms of their working volume.  
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Extrusion-based bioprinting, due to its popularity, also has many modified forms and available products 
for purchase. Popular, commercially available bioprinters include 3D Bioplotter (EnvisionTEC), NovoGen MMX 
(Organovo), BioBot (BioBot), BioAssemblyBot (Advanced Solutions), Bioscaffolder (GeSim) and the 3D 
Discovery (RegenHU). Most of these printers dispense by a mechanically or pneumatically driven piston, and the 
higher-end printers usually also have some special modifications to this simple set-up. For example, the 3D 
Discover bioprinter (RegenHU), which was also the bioprinter used to complete the work presented in this 
dissertation, uses a magnetically-driven spring to open and close a valve, that is, the company created valve-
assisted extrusion printing Figure 13. This modification allows for much more precise control over viscous 
hydrogels.  
 
 
Figure 13: The microvalve used in microvalve-assisted printing from RegenHU. The ball valve is 
comprised of an electromagnetically-dr iven spring, a ball (pink) and the seat (clear with 
opening). Reproduced with modifications from RegenHU user manual v1.4, page 26, figure 23.  
 
The performance of a biofabricated construct by 3D bioprinting is subject to the type of 3D bioprinter and the 
bioink (biomaterial and cell types) that are used. Evaluating bioprinted scaffolds is further complicated by the fact 
that the choice of bioprinter and bioink cannot be made independently from each other, so these variables must 
be tested in combination, as well as separately.  
 
1.4.3 Evaluating 3D bioprinted scaffolds 
 
As discussed in previous sections of this dissertation, there are several important characteristics that 
biomaterials must have, as well as biomaterials used for biofabrication. 3D bioprinted scaffolds should the 
scaffolds should also be evaluated before, during and after printing to fully understand the effect the process has 
on the outcome. For example, within an unprinted bioink the cells may be viable and proliferate, however, after 
being exposed to mechanical stress during printing the viability might be low and/or the proliferation is inhibited 
[151, 152]. In other words, the relationship between the bioink and the 3D bioprinter on the performance 
outcome must be evaluated in a time-dependent manner, Figure 14.  
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Figure 14: Evaluating 3D bioprinted scaffolds before (1,2) during (3) and after (4,5) printing. 
Important parameters to evaluate are materials properties (1,3,4), printability (4) and the 
response of cel ls (2,5).  
 
Although there are many elements to the printing process that could affect the bioink, the essential variable is 
exposure to shear stress. The exposure to shear stress can result in changes and/or damage to the polymer 
network. As stated in previous sections, this will result in a change in the mechanical behavior, the degradation 
behavior, and the ability of molecules to diffuse through the mesh (the porosity of the mesh), which will further 
result in effects on the cell behavior. The shear stress can also have direct influence on the encapsulated cells; if 
shear stress is too high it will result in reduction in viability and in proliferation potential. The reduction in 
proliferation can be due to cell destruction (lower seeding density) as well as an increase in the amount of stress 
factors (reduces the proliferation potential of remaining viable cells) [151, 153]. However, likely due to the short 
exposure time to high pressure or shear stress, cells usually recover to a high viability [153, 154] and it does not 
typically effect cell phenotype [153]. In spite of challenges associated with 3D bioprinting, it is worth investing 
time and effort into optimizing a system such that it is compatible with 3D bioprinting. This is because, when the 
system is optimized, 3D bioprinting significantly expands the possibilities, making for some quite dazzling 
examples of tissue engineering. 
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1.4.4 State-of-the-art in 3D bioprinting 
 
Given a suitable bioink or bioinks, 3D bioprinting can be used to generate an endless number of structures and 
scaffolds. Although there are many reasons why this is incredibly useful, I would propose there are two reasons 
why this is so relevant and significant to current research: for the development of pre-vascularized scaffolds, and 
to create physiologically-relevant, composite/gradient scaffolds: 
 
The importance of pre-vascularization has been demonstrated several times as large scaffolds, without 
any pre-vascularization, will usually develop a necrotic core when implanted [155].  
 
Normal adult tissues are highly complex with a hierarchy of ECM molecules, cells types and structures. 
Within tissues and tissue niches, these distinct microenvironments are not sharply demarcated, but 
rather have gradient interfaces. These gradients can include incremental changes in cell types, growth 
factors, ECM molecules, arrangement of ECM molecules, and so forth.  
 
Although pre-vascularization seems like a specific topic, there are a diverse number of approaches to pre-
vascularizing scaffolds using 3D bioprinting. In a study by Kolesky et al. 2014, they combined GelMA loaded with 
either human neonatal dermal fibroblasts (HNDFs) or mouse fibroblast cell line 10T ½, and printed sacrificial 
channels made of Pluronic [156]. After removing the sacrificial ink, the remaining channels were then perfused 
with human umbilical vein endothelial cells (HUVECs). After two days in culture, it could be demonstrated that 
the HUVECs lined the inner lumen, and that the scaffolds could be perfused without losing the distinct fibers of 
different cell types. In a further study, they were able to demonstrate the flexibility of 3D printing by printing a 
perfusion chamber around their scaffold [157]. By combining vascular structures with a perfusion chamber, they 
were able to promote the differentiation of MSCs into bone-like tissue that exceeded 1 cm in thickness. In an 
alternative approach, hollow channels were generated by printing using a co-axial needle set-up [158]. Using 
alginate- based bioink, they printed into a CaCl2 bath as well as perfused CaCl2 through the core of the alginate 
bioink, leading to rapid fabrication of hollow fibers with viable cells, which could later be perfused with media.  
There are also alternative methods to developing pre-vascularized scaffolds in the early stages of 
development. Due to the approaches’ high potential, they will also be mentioned here. One technique is to print 
relatively flat, 2D structures that will later fold into the vasculature in response to a stimulus (e.g. osmotic 
pressure, magnetic field). This combination of 3D bioprinting and origami, often referred to as “4D bioprinting”, is 
advantageous because it eliminates the need for a sacrificial ink or media, which can potentially effect cell 
viability, to support the inner vascular structure until the printing process is complete. This disadvantage is that it 
is more difficult to directly integrate into a tissue-like scaffold, and after printing you have a free-standing 
vasculature which needs to be incorporated into a tissue in a second processing step. Currently, to the best of 
my knowledge, studies using 4D bioprinting approaches are limited to single tubes or single structures, and has 
yet to be used for creating a complete vascular network [159]. Another alternative to directly printing tubes is to 
print the “negative space” into a matrix using some sort of media or hydrogel to be removed later. In a study by 
Wu et al., they printed a fugitive ink into a Pluronic hydrogel-based matrix. This set-up allows for “defying 
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gravity”, and allowed the authors to create a free-standing, high-resolution vascular network. Although this 
approach was cell-free and requires quite a bit of modification to become a tissue, the method has high potential 
of the application to combine complex curvature with a complex hierarchy [160]. 
Although it is important to pre-vascularize scaffolds, as stated previously, it is not the only significant 
factor to consider; it is also necessary that constructs contain structural, material and growth factor gradients. 
For example, pore size can play a major role outside of improving the diffusion of nutrients or cell seeding 
efficiency. In a study by Trachtenberg et al., they examined the effect of pore size and gradient pores and their 
orientation, both in static conditions and under perfusion [161]. From this study they were able to demonstrate 
that pore size gradients and scaffold orientation relative to the flow direction, different shear stress profiles were 
produced, which effected not only cell viability about also cell differentiation. This being not only interesting from 
the perspective of tissue engineering, but also for scientific studies on cell biology.  
 Another interesting approach is to create composite scaffolds. In a study by Xu et al., they were able to 
hybridize a solvent electrospinning and inkjet bioprinting process to create scaffold for cartilage tissue 
engineering [162]. By hybridizing the two morphologies, they were able to improve the mechanical properties as 
well as improve performance of composite, cell-loaded scaffold in vivo. In particular, they were able to show 
increased production of GAGs and collagen II in cell-loaded versus cell-free scaffolds, indicating better cartilage 
formation. By extension, this study exemplifies the significance of bioprinting over cell-free, printed scaffolds. To 
the best of my knowledge, there are no other examples of bioprinting with electrospinning, although there are 
interesting examples of melt-electrospinning [163] and extrusion printing combined with electrospinning [164] to 
make cell-free scaffolds with micro and nano-sized features, which could represent potential future technologies 
to adapt such that they can be combined with 3D bioprinting.  
There are countless examples of well-designed, multi-material bioinks [138]; however, in the examples 
above with modified printing techniques, almost all used “simple” bioinks. Although they represent incredible 
progress in the field, the “next generation” of bioinks need to be fabricated. I would propose that would be 
bioinks need to contain microenvironments. In a study by Du et al, they encapsulated 22 µm long, BMP-2 
functionalized collagen microfibers into a GelMA-based bioink with human mesenchymal stem cells (hMSCs) 
[165]. Using the complete set-up, they were able to demonstrate upregulation of osteogenic markers compared 
to all control groups.  
Although the examples presented here are quite impressive, development of bioinks and 3D bioprinting 
techniques need to be taken further, in particular the most novel bioprinting techniques and bioinks need to be 
combined into one complete system. This dissertation presents progress on the use of recombinant spider silk 
proteins, a powerful biomaterial platform, for use in biofabrication. 
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2. Aim 
 
The aim of this project is to use electrospinning (ESP) and 3D bioprinting (3DBP) biofabrication techniques to 
create bioactive or tissue engineered constructs using recombinant spider silk protein eADF4(C16) as one of the 
principle biomaterials.  
 
The main motivations behind this objective is to enable the production of complex scaffolds comprised of 
recombinant spider silk protein. All human tissues are made up of multiple materials, cell types (or sub-types), 
biological agents, and geometries. Recombinant spider silk proteins represent a unique tool to develop 
biomaterials with specific biological characteristics. Further, cells respond differently to each dimension (1D, 2D, 
3D); therefore, having multiple scaffold morphologies is a powerful tool to guide cell behavior. Due to the broad 
range of dimensions covered between electrospinning and 3D bioprinting, they were the chosen processing 
techniques to develop.  
 
Due to the breadth of this objective, it has been broken down into three objectives:  
 
Objective (1) is to develop and characterize an aqueous spinning dope as well as aqueous post-
treatment process of recombinant spider silk proteins in order to improve the biocompatibility of the 
process. In previous publications, the solvent used for electrospinning eADF4(C16) was HFIP, and the 
post-treatment method was 60 °C, 100 % ethanol vapor. This “toxic” method was the control for the 
characterization of the all-aqueous system that was developed. 
 
Objective (2) is optimize and characterize previously established eADF4(C16) and eADF4(C16)-RGD 
bioinks for cell response and material properties. In particular, bioinks should be tested before and after 
printing for short-term cell viability, gelation-rate, rheological behavior, and long-term proliferation. 
 
Objective (3) is to optimize the 3D bioprinting with recombinant spider silk bioinks. The printability of 
eADF4(C16) and eADF4(C16)-RGD based on the appearance of printed fibers and scaffolds, as well as 
their rheological properties.  
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3. Synopsis 
 
This dissertation is comprised of two first author research publications (publication 1 and publication 2), one 
second author research publication (publication 4), two first author review articles (publication 5 and 
publication 6), one second author submitted research article (publication 3) and unpublished research. The 
publication list is found in section 5; my contributions to each publication are described in section 6.  
Engineered Araneus diadematus fibroin 4 with 16 repeat C-module (eADF4(C16)) recombinant spider 
silk proteins, or variants thereof, were used for the research presented in this dissertation. Recombinant spider 
silk variants eADF4(C16), eADF4(C16)-RGD and eADF4(κ16) are well established biomaterials for tissue 
engineering and regenerative medicine, even compared to other recombinant silks, as reviewed in publication 5. 
eADF4(C16)-RGD refers to the variant of eADF4(C16) with and RGD peptide introduced at its C-terminal end, 
and eADF4(κ16) where the glutamic acid (E) residue found in the C-module is switched out for a lysine (K), 
resulting in a net positive charge. Examples of the use of these proteins for tissue engineering include 
electrospinning eADF4(C16) to produce nonwovens that enhance cell attachment compared to films [110], 
patterning films of eADF4(C16) and eADF4(κ16) to enhance cell attachment [109], casting films from 
eADF4(κ16) alone for cardiac cell culture [108], developing foams of eADF4(C16) and eADF4(C16)-RGD to 
improve waste and nutrient transport to 3D cell cultures [123], and 3D bioprinting with eADF4(C16) and 
eADF4(C16)-RGD hydrogels [166]. Although these were successful, all except one of these examples used 
classical tissue engineering approaches. As previously stated, the disadvantage of this is that the fabrication 
time is long, and there are potentially toxic byproducts.  
The aim of this work was to adapt protocols to allow for biofabrication using recombinant spider silk 
proteins, in particular for use in robotic dispensing and electrospinning. These two techniques were chosen 
because of the possibility to produce a broad range of substructures in the scaffolds from nanometers 
(electrospinning) to micrometers (electrospinning/3D bioprinting) to millimeters and centimeters (3D bioprinting). 
The adjustability of these patterns is of importance when attempting to create functional tissues or organs.  
The general processing of the silk proteins includes solubilization and dialysis to create the variously 
concentrated solutions suitable for either 3D bioprinting or electrospinning, Figure 15.  
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Figure 15: The processing steps to produce eADF4(C16) and eADF4(C16) -RGD solutions for the 
studies presented in this dissertation. Steps found in the black squares are common steps to 
both protocols, green circled steps are those specific to the electrospinning dope preparat ion,  
and pink rounded square steps are those specific to the bioink preparat ion.  
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eADF4(C16) had been previously used for electrospinning nonwoven mats for developing vacuum filters [92, 
167] and for basic in vitro studies [110]. However, in these studies eADF4(C16) was dissolved in a volatile, 
organic solvent (Hexafluoroisopropanol, HFIP) and post-treated using 100 % ethanol (anhydrous, denatured) 
vapor (60 °C) to induce secondary structure formation (render water insoluble). These conditions are typically 
not compatible with biological activity of biomacromolecules as well viability of cells, making encapsulation of the 
bioactive components via in vitro electrospinning impossible. Further, if implanted in vivo, it is possible that 
residual HFIP inside of the fibers could damage local tissue or cause an immune response. Therefore, 
development of an all-aqueous electrospinning process was crucial to introduce this technique into the 
biofabrication field. To achieve this goal, the solvent was change to Tris buffer, and water annealing at 37 °C was 
used for post-treatment. This was shown to improve the fluorescence activity of green fluorescent protein (GFP) 
compared to the traditional method (unpublished research).  
Based on pilot studies by Schacht et al. 2015 [166], which are reviewed in publication 6, it was clear that 
there is an effect of cell culture medium as well as the RGD peptide sequence on the formation and properties of 
the eADF4(C16) and eADF4(C16)-RGD hydrogels. Therefore, the effect of these on hydrogel assembly was 
determined in publication 2. Related works discusses the potential mechanisms behind the increased gelation 
kinetics and stiffer properties in the presence of cell culture media, as well as the difference in behavior of 
eADF4(C16) and eADF4(C16)-RGD hydrogels. These properties being of utmost importance, as gelation 
kinetics have a large impact on cell viability, mesh network and size have a large effect on cell proliferation, cell 
morphology, and oxygen/waste/nutrient diffusion, and mechanical properties partially determine cell 
differentiation. Further, change the mechanical properties can also significantly influence the printability of the 
bioink, which was also studied in a second author publication by comparing eADF4(C16) and engineered major 
ampullate spidroin 1 short (eMaSp1s) hydrogels in publication 4. Using this basic information on the behavior of 
the bioinks, they could be optimized to overcome previous shortcomings as shown in publication 1. In this study 
we focused on the effect printing on basic cell behavior (viability and proliferation), as well as methods to 
improve printability by use of gelatin in the bioink formulation. Further, in publication 3 it was demonstrated that 
the bioink exhibits antimicrobial behavior, indicating the high potential of recombinant spider silks for 
biofabrication due to both their inherent properties, reviewed in publication 5, as well as their flexibility for 
modification (e.g. addition of RGD peptide). 
 
3.1 Electrospun eADF4(C16) nonwovens from aqueous solution and aqueous 
post-treatment process  
 
Although there are many benefits to using an aqueous solution for electrospinning, as indicated in the motivation 
and aim of this dissertation, it is more challenging than in traditional approaches. One of the main determinates 
of the ‘spin-ability’ of a solution is its viscosity, which is ultimately determined by its concentration, molecular 
weight and to a minor degree the solvent it is dissolved in [168]. The aqueous solution of eADF4(C16) has a 
maximum concentration of 7 % (wt/vol) [86], which is close to the minimum concentration for electrospinning in 
HFIP (6 %) [92]. Therefore, it is not surprising that aqueous solutions comprised of eADF4(C16) alone could not 
be electrospun. Based on literature of silk fibroin [168, 169], PEO was chosen to use as an additive as a fiber 
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forming agent. Therefore, an aqueous electrospinning dope was prepared by blending PEO weight-to-weight 
with eADF4(C16) one to three (3 mg of eADF4(C16) to 1 mg of PEO), and, to the best of our knowledge, this is 
the first-time spider silk protein was electrospun from aqueous solution, [170]. The usable concentration range 
was determined as between 4.5 % and 5 %; concentrations below 4.5 % resulted in highly beaded fibers and 
above 5 %, the protein aggregated excessively or spontaneously gelled during dialysis. Due to the narrow 
concentration window of “spin-able” eADF4(C16) solutions, it was not possible to alter the fiber diameter, and the 
average fiber diameter was determined to be ~240 nm.  
Generally, the spider silk scaffolds generated out of the HFIP solution (casted films, electrospun mats) 
contain low amounts of beta-sheets (~20 %) and high amounts of amorphous protein structures, rendering them 
water-soluble. Thus, post-treatment is generally applied to induce the protein folding into beta-sheet rich 
structures (to ~40 %) rendering scaffolds water-insoluble. There are several post-treatment methods available; 
usually alcohol vapors of MeOH, EtOH or i-PrOH, sometimes mixed with water, are used [126]. Alternatively, 
silks fibroin scaffolds could be post-treated by water vapors at increased temperature (annealing) [171, 172]. 
These two types of post-treatment, alcohol-based and water-based, work by opposite mechanisms. Ethanol 
dehydrates the proteins and induces inter- or intramolecular hydrogen bond formation whereas water annealing 
allows incorporation of water molecules that act as plasticizers and thereby introduce more chain flexibility. 
These post-treatment methods are further concomitant with increasing temperature enhancing hydrophobic 
effect responsible for beta-sheet formation in polyalanine regions of the protein sequence [173]. In this study we 
compared both methods of post-treatment, and both resulted in similar secondary structure content (~40 %), 
independent of the solvent system used (HFIP or 10 mM Tris buffer supplemented with PEO), as determined by 
FSD analysis of FTIR spectra [174]. To demonstrate the significance of this all-aqueous system in potential 
applications, green fluorescent protein (GFP) was incorporated into electrospinning dopes as a model of 
bioactive molecule, Figure 16.  
 
 
Figure 16: The bioactivity of GFP after electrospinning and after ethanol vapor or water vapor 
post-treatments at two different temperatures, 37  °C and 60 °C. Modified from DeSimone, E., 
Aigner, T., Humenik, M., Lang, G. and Scheibel T., Aqueous electrospinning of recombinant 
spider si lk proteins. Materials science & engineering. C, Materials for biological applications, 
2020. 106: p. 110145. [170]; as the author of this Elsevier artic le, I retain the right to include it  
in a thesis or dissertation, provided it is not published commercially.  
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Addition of GFP into HFIP solution of eADF4(C16) resulted in apparent loss of the fluorescence activity caused 
by disruption of GFP tertiary structure. Conversely, mixing the GFP into water-based eADF4(C16)/PEO dopes 
resulted into fluorescent nonwovens, indicating native GFP conformation. Further, the post-treatment in ethanol 
also had a negative effect on the fluorescent activity of GFP; the bioactivity was completely diminished after the 
ethanol vapor treatment. This is likely due to rapid dehydration disrupting the GFP structure. Further, the post-
treatment could also be performed at 37 °C, which also improved GFP activity, and would be necessary for 
directly electrospinning onto cells in vitro or wounds in situ.  
Overall, the significance this work in future development is utilization the all-aqueous approach for 
biofabrication, e.g., in vitro electrospinning directly on top of cells or hydrogels encapsulating cells, incorporation 
of growth factors or as biosensors. Another significant point is that it is possible that the all-aqueous production 
could influence the behavior of cells [171], and would likely influence the reaction to the nonwoven in vivo. 
Further, drug encapsulation and release studies could be done, and in order to regulate the release kinetics of 
the biological agents, the genetic fusions of the protein of interest with the recombinant spider silk eADF4(C16) 
can be used to anchor them to the eADF4(C16) based nanofibrillar scaffold [175]. The positively charged variant 
of the silk protein eAF4(κ16) could be also used to prepare eADF4(C16)/(κ16) blend nonwovens, which enable 
regulation of the release kinetics according to change of the biological agent. 
 
3.2 Recombinant spider silk bioinks  
 
In the pilot studies of 3D bioprinting with eADF4(C16) and eADF4(C16)-RGD hydrogels it was observed that cell 
culture media and the addition of the RGD peptide have effects on the material properties of the hydrogels. 
Therefore, the studies presented in publication 2 concentrated on determining the effect of cell culture media on 
the hydrogels as well as the effect of the RGD peptide tag. The addition of cell culture media (referred to as 
DMEM in the publication text) to highly concentrated hydrogel precursor solutions did not change the fibril 
morphology of eADF4(C16) or eADF4(C16)-RGD hydrogels, as determined using transmission electron 
microscopy (TEM). However, there was increased gelation rate (turbidity measurements), increased the stiffness 
of the hydrogel (quasi-static rheology measurements) and increased the viscosity of hydrogels (flow shear ramp) 
in the presence of cell culture media. The increased rate of hydrogel formation, and subsequent increase in the 
hydrogel stiffness, could be explained by the positive ions in solution, such as Ca2+, interacting the negatively 
charged glutamic acid residues between the protein chains [176]. To test this hypothesis, specific concentrations 
of CaCl2 was added to hydrogel solutions, and a similar effect was observed, where the addition of CaCl2 
increased the stiffness of the hydrogels, implying that it is decreasing solubility and supporting ionic network 
formation, Figure 17.  
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Figure 17: Rheological character ization of hydrogels made of recombinant spider silk proteins.  
Stress-strain curves of 3  % w/v eADF4(C16) and 3  % w/v eADF4(C16)-RGD hydrogels in the 
absence and presence of 5 mM CaCl2 and DMEM (15 % v/v). Reproduced from Materials 
Letters, 183, DeSimone E., Schacht K., and Scheibel T. Cations influence the cross- linking of 
hydrogels made of recombinant, polyanionic spider silk proteins , 101-104, 2016 [177]; as the 
author of this Elsevier art icle, I retain the right to include it in a thesis or dissertation, provided it 
is not published commercial ly. 
 
Addition of the RGD peptide had similar effects to cell culture media, albeit less pronounced. For example, 
although there was an increase in the gelation rate and the stiffness, the rheology tests conducted at higher 
shear rates showed that viscosity of eADF4(C16) and eADF4(C16)-RGD are identical. It is known from previous 
work that eADF4(C16)-RGD particles have a lower zeta potential than eADF4(C16) particles [178]. Therefore, 
the attraction between the proteins of the RGD variant seem to be higher, which could explain some of these 
differences seen in the quasi-static testing of the hydrogels. However, the increased interactions are likely weak 
and easily disrupted, as the stiffening effect of the RGD sequence was not observed in shear sweep tests [139, 
179]. Further supporting this point is that the increase in stiffness by the RGD peptide was minimal compared to 
adding the cell culture media, and at the high concentrations of cell culture media there was no longer a clear 
effect of the RGD peptide. Overall, the studies presented in publication 2 could be used to enhance the 
performance of bioinks in further studies presented in publication 1. In the next figure captions for figures 18, 19 
and 20, different experimental groups will be abbreviated as seen in the legend in publication 1, provided again 
below.  
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Legend 
 
20 mg/mL eADF4(C16) (15-% DMEM),  
1x106 BALB3T3/mL of hydrogel 
 
2C-D15-B 
30 mg/mL eADF4(C16) (15-% DMEM) 
1x106 BALB3T3/mL of hydrogel 
 
3C-D15-B 
40 mg/mL eADF4(C16) (15-% DMEM) 
1x106 BALB3T3/mL of hydrogel 
  
4C-D15-B 
30 mg/mL eADF4(C16) (15-% DMEM) 
1x106 BALB3T3/mL of hydrogel  
 
3C-D5-B 
30 mg/mL eADF4(C16) (5-% DMEM),  
1x106 BALB3T3/mL of hydrogel 
0.15 mg/mL gelatin 
3C-D5-g-B 
20 mg/mL eADF4(C16)-RGD (15-% DMEM),  
1x106 BALB3T3/mL of hydrogel 
 
2R-D15-B 
30 mg/mL eADF4(C16)-RGD (15-% DMEM) 
1x106 BALB3T3/mL of hydrogel 
 
3R-D15-B 
20 mg/mL eADF4(C16)-RGD (5-%  DMEM),  
1x106 BALB3T3/mL of hydrogel 
  
2R-D5-B 
20 mg/mL eADF4(C16)-RGD (5-% DMEM),  
1x106 BALB3T3/mL of hydrogel  
0.1 mg/mL gelatin 
2R-D5-g-B 
 
An example where the data collected in publication 2 informed publication 1 is the gelation kinetics data, the cell 
seeding protocol could be optimized such that cell viability is nearly 100 % after encapsulation inside of the 
hydrogels. With the cell encapsulation protocol optimized, the cells were also able to proliferate in the 
eADF4(C16)-RGD bioinks, Figure 18. 
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Figure 18: Proliferation of mouse fibroblasts cell line BALB3T3 in unprinted bioinks over 15 d as 
measured by: (A) Absorbance of cel l t iter blue (B -D) Fluorescence microscopy images of cells 
stained with calcein A/M (live cells: green) and ethidium homodimer I (dead cells: red) (scale 
bars = 250 µm) and (E-J) photographs of cylinders (diameter = 0.65 cm) removed from cell 
culture inserts (B) 3C-15D-B, (C) 2R-15D-B, (D) 3R-15D-B, (E) 3C-15D, (F) 3C-15D-B, (G) 2R-
15D, (H) 2R-15D-B, (I) 3R-15D, (J) 3R-15D-B. Three to four samples were measured per 
experimental group (n = 3-4). Standard deviation is indicated using error bars.  Reproduced from 
Biofabricat ion, 9, DeSimone E., Schacht K., Pellert A., Scheibel T. Recombinant spider silk-
based bioinks, 044104, 2017 with permission from IOP Publishing [179].  
 
There was no difference in the proliferation of cells in 2 % and 3 % eADF4(C16)-RGD bioinks, however, due to 
the different protein concentrations, the mechanical stiffness for each bioink was different. Therefore, given that 
there was no clear difference in the proliferation of cells in 2 % and 3 % eADF4(C16)-RGD, and to match the 
gelation kinetics and mechanical properties, the concentration of eADF4(C16)-RGD was reduced to 2 % (20 
mg/mL). The cell culture media concentration was reduced from 15 % to 5 % to improve the homogeneity of the 
bioink, and there was no difference found in terms of cell viability and proliferation upon this change. Gelatin was 
tested at as an additive to improve printability, and had no significant effect on the stiffness of the hydrogels, 
Figure 19. 
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Figure 19: Young’s modulus calculated using Hooke’s law for 3C-5D, 3C-5D-g, 2R-5D, and 2R-
5D-g. Three to four samples were measured per experimental group (n = 3 -4). Asterisks indicate 
significance differences in the mean where * indicates significance level α = 0.05, No significant 
difference were found using a significance level of α = 0.01. Standard deviation is indicated 
using error bars.  Reproduced with modificat ions from Biofabrication, 9, DeSimone E., Schacht 
K., Pellert A., Scheibel T. Recombinant spider silk-based bioinks, 044104, 2017 with permission 
from IOP Publishing [179]. 
 
BALB3T3 cells (mouse fibroblasts) cannot differentiate between a Young’s modulus of 3.5 kPa and 5.5 kPa 
[180]. For this reason, the fact that the moduli are statistically significant different from each other was 
considered not important, and the bioinks were considered appropriate choices for use in further experiments.  
2 % eADF4(C16)-RGD bioinks were more appropriate to compare to 3 % eADF4(C16) in terms of static 
3D cell culture, however, it was found that under printing conditions the eADF4(C16)-RGD bioinks were softer 
and had lower printability. Further, although the resolution of eADF4(C16) bioinks could be improved by the 
addition of gelatin, however no clear changes were observed for the eADF4(C16)-RGD bioink, Figure 20.  
 
 
Figure 20: Recovery of bioinks after a large, non-linear deformation and printed 2-layer 
scaffolds. Reproduced with modifications from Biofabricat ion, 9, DeSimone E., Schacht K., 
Pellert A., Scheibel T. Recombinant spider silk-based bioinks, 044104, 2017 with permission 
from IOP Publishing [179]. 
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The dynamic viscosity of the 2 % eADF4(C16)-RGD bioink at a higher shear rate, e.g., under printing conditions, 
was lower than 3 % eAD4(C16). In oscillation measurements, the 2 % eADF4(C16)-RGD bioink was much 
weaker (in terms of storage and loss modulus) than the 3 % eAD4(C16) bioink. However, in shear ramp data, the 
viscosity of the two bioinks, 2 % eADF4(C16)-RGD and 3 % eAD4(C16), was found to be nearly the same. The 
discrepancy between data collected from flow measurements and oscillation measurements could be explained 
by the fact that in the flow measurements absolute or dynamic viscosity are measure (inherent resistance to 
flow) whereas in oscillation measurements intramolecular forces or kinetic viscosity (density-dependent instead 
of force dependent) are measured. Therefore, there are fewer molecular chains or ionic bonds to break in the 
lower concentration bioink, however, due to the weak interactions of RGD the overall resistance to force is 
higher. Regardless of the mechanism, this lower storage and loss modulus led to the eADF4(C16)-RGD bioinks 
to have a lower resolution and shape fidelity.  
Although gelatin improved the resolution of the eADf4(C16) bioink there was no clear difference in the 
shape fidelity, the viscosity or in the recovery behavior of the bioinks containing gelatin. This indicates that the 
gelatin might improve the homogeneity or stress-relaxation of the bioink, possibly acting as a plasticizer by 
binding more water molecules [181]. Further, both eADF4(C16) and eADF4(C16)-RGD exhibited rapid recovery 
to nearly original values for storage modulus, and over the course of 5 minutes had complete recovery. Although 
this behavior is important for printing and high shape fidelity, it is also necessary to have high storage and loss 
modulus to have high printability, as is evident from the 2 % eADF4(C16)-RGD bioinks. The low viscosity could 
explain why, although the cell viability after encapsulation in the hydrogels was improved, the post-printing cell 
viability was not improved in comparison to the initial study [166].  
The reason behind reduced cell viability could be mechanical shear stress during the printing process, 
dehydration of the bioink before additional cell media could be added, or both. Although no cell proliferation was 
observed, the cells that survived the printing process were still viable, although they retained a round 
morphology, indicating that there was no cell spreading or maturation. There are a few possible explanations for 
this behavior. One is that the hydrogel network is too dense for the cells to spread and proliferate without 
degrading the matrix, however degrading the matrix is difficult with low cell number, and therefore the cells 
remained viable, but were caged [182, 183]. A second possible reason is that the cells that remained viable were 
under stress (mechanical shear from printing, exposure to debris from perished cells) and became senescent 
[151].  
Future work for this project would be to use higher concentrations of bioinks or to add additional 
crosslinkers to the bioinks in order to increase the viscosity, which improves the post-printing viability, however 
has to be balanced with preventing reduction of cell proliferation. Further, the seeding density could be 
increased, which could improve the post-printing viability and proliferation.  
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3.3 Conclusion and outlook 
 
Throughout these studies it was demonstrated that recombinant spider silk protein eADF4(C16) and its variant 
eADF4(C16)-RGD can be used for biofabrication. Highlights of this work include demonstrating the maintained 
bioactivity of GFP in the electrospun nonwovens prepared using the all-aqueous route, rheological studies that 
elucidated some possible deterministic properties of printable bioinks and the proliferation of cells encapsulated 
in unprinted eADF4(C16)-RGD bioinks. Interesting future improvements to the scaffolds presented here could 
include tailoring the release of biological agents from the nonwovens and enhancing viability and proliferation of 
cells within printed bioinks. Larger projects based on this work could include creating composite scaffolds with a 
hybridized electrospinning and bioprinting process, composite bioinks with electrospun fibers, or blended bioinks 
with other biopolymers to optimize the properties or towards a specific application.  
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Abstract  
Antimicrobiotic-resistant microbial strains are a major problem in health care and are increasing in number at an 
alarming rate due to the overuse of antimicrobial agents. Therefore, there is a great interest in developing 
advanced materials that are selectively inhibiting microbial growth (i.e. their adhesion) without actively killing 
microbes and simultaneously promoting mammalian cell growth (i.e. by promoting adhesion and proliferation). 
Microbe repellence is a specific feature of some natural spider silks. To unravel how microbe repellence can be 
achieved in man-processed materials, different recombinant spider silk proteins based on the consensus 
sequences of Araneus diadematus dragline silk proteins (fibroin 3 and 4) were processed into 2D-patterned films 
and 3D-hydrogels. Strikingly, protein structure characteristics on the nanoscale are the basis for the detected 
microbe-repellence. Designed spider silk materials promoted mammalian cell attachment and proliferation while 
inhibiting microbial infestation, indicating the great potential of these engineered spider silk-based materials as 
bio-selective microbial-resistant coatings in biomedical and technical applications as well as for hydrogel-based 
tissue regeneration. 
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1. Introduction 
Pathogenic microbial contaminations of surfaces, when exposed to patients, significantly increase the risk of 
infection and represent a severe problem in the public health care sector.[1,2] Biofilm formation on biomedical 
devices, such as prosthetics, medical implants, contact lenses, and catheters, not only limits their functionality 
and lifetime but can also cause life-threatening infections.[3,4] Consequently, microbial biofilm generation and 
nosocomial infection during conventional medical therapy have significantly increased mortality as well as 
healthcare costs worldwide in the last decade. Outside of the clinical setting, diseases associated with food 
contamination as well as biofouling of material surfaces in contact with water supply systems are considered 
major health issues.[5] There are several interacting parameters that have ultimately led to this problem, however, 
the most critical is the evolution of antimicrobial-resistant (or even multi-drug resistant)[6] microbes due to the 
overuse of antibiotics.[7,8] Furthermore, microbial colonization can subsequently lead to formation of almost 
irremovable biofilms, hardly accessible for antibiotics as, after becoming a dense colony, the microbes secrete a 
protective coating, making it much more difficult to eradicate biofilms in contrast to isolated microbes.[9,10] 
One example of a “superbug” is methicillin-resistant Staphylococcus aureus, a major cause of community-
acquired infections resulting in high morbidity and mortality rates in hospital-acquired infections.[11] Concerning 
treatment of these infections, glycopeptide antibiotics (GPAs) targeting the acyl-D-alanyl-D-alanine (D-Ala-D-Ala) 
terminus of the growing peptidoglycans on the outer surface of the Gram-positive bacteria’s cytoplasmatic 
membrane are considered the last, non-antibiotic resort for medical treatment.[12] Nevertheless, glycopeptide-
resistant organisms cause new problems, as they significantly reduce antibiotic affinity by replacing the D-Ala-D-
Ala terminus with D-alanyl-D-lactate (D-Ala-D-Lac) or D-alanyl-D-serine (D-Ala-D-Ser), prompting the search for 
second generation drugs and new strategies to inhibit spreading of such pathogens by new hygiene standards 
and for materials with explicit repelling surfaces.[13] In this context, biomaterials with inherent non-fouling 
properties would provide new opportunities of long-term protection, especially when they can be used as surface 
coating materials for already existing products. However, one draw-back of such surfaces is that they often repel 
any kind of cells, even human ones, making it difficult to employ them in applications such as tissue 
engineering.[14]  
As one critical step in biofilm formation is the initial adherence of pathogenic microbes onto a material’s 
surface,[9] inhibiting microbial attachment is a favorable approach to develop material surfaces resistant to biofilm 
formation.[15,16] There are two main approaches for inhibiting surface attachment, referred to as either active or 
passive resistance. While passively resistant surfaces are typically made of super hydrophilic or hydrophobic as 
well as zwitterionic or other synthetic polymers,[17-19] actively resistant ones are often “contact killing” materials, 
such as cationic polymers, amphiphilic polymers, antimicrobial peptides and polymeric/composite materials 
loaded with antimicrobial agents.[20-25] Although these approaches can combat microbial infection by inhibiting 
mechanisms of persistence and adaptation, several drawbacks exist, such as instability under physiological 
conditions, cytotoxicity to mammalian cells, inflammatory responses, a narrow antimicrobial spectrum, and 
implications for transmitting multidrug resistance.[26] Further, antimicrobial activity has been mostly investigated in 
terms of its effectiveness against bacteria, although fungal infections also contribute significantly to patient 
morbidity and mortality. Moreover, fungal infections can readily form polymicrobial biofilms with enhanced 
resistance to antifungal drugs, further limiting therapeutic options.[27] Therefore, efficient mitigation of microbial 
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infection associated with both bacteria and fungi is required for the future development of broad-range 
multifunctional material coatings. 
Spider silk exhibits extraordinary mechanical properties, surpassing the toughness of other polymer fibers, and 
further displays excellent biocompatibility useful for biomedical applications.[28,29] Remarkably, most spider silk 
webs withstand microbial omnipresence and remain resistant to microbial decomposition for years, irrespective 
of environmental impacts such as humidity, temperature, and location, though being composed of proteins and 
therefore of amino acids, which would be a valuable source of nutrition for microbes. Only few studies have been 
published examining microbe-repelling effects of natural spider silk,[30] and so far, the underlying mechanism 
remains ambiguous. This is because the surface of silk fibers consists of varying mixtures of spidroins, 
glycoproteins and lipids, and the composition of the surface further depends on the spider species as well as 
environmental conditions.[31] In some cases, even antimicrobial peptides might be implemented recombinantly to 
the spider silk coatings. [32,33] Consequently, the resistance of spider silk fibers against microbial infestation has 
so far only been macroscopically described, but not assigned to single material components such as lipids, 
glycoproteins, silk proteins or material features of these composite materials. Recently published results indicate 
that bacterial infestation and decomposition of spider silk is inhibited by bacteriostatic activity rather than by anti-
bacterial means.[34,35] The authors further hypothesized, that the complex network of interconnected crystalline 
and non-crystalline structures might prevent accessibility of nitrogen, which is necessary for bacterial growth.  
Here, 2D and 3D scaffolds based on explicit individual recombinant spider silk proteins, based on sequences of 
the dragline silk of the European garden spider Araneus diadematus, were found to withstand microbial 
infestation depending on the structural features of the material's surfaces. Two engineered Araneus diadematus 
fibroins eADF3 and eADF4 and variants thereof were utilized, based on consensus sequences of the core 
domains of the naturally occurring fibroins 3 and 4.[36,37] Materials made thereof polyanionic eADF4(C16), the 
best investigated of these variants, display absence of toxicity, lack of immune reactivity and slow 
biodegradation.[38,39] As eADF4(C16) lacks cell binding motifs, like most so far identified spider silk proteins, 
eADF4(C16)-coated implants and catheters display a significantly reduced adhesion and proliferation of 
mammalian cells as compared to non-treated ones.[40,41] When transplanted in vivo in rats, eADF4(C16)-coated 
silicone implants exhibited a substantial reduction in capsular fibrosis.[40] However, cell attachment to eADF4-
based materials could be promoted by generating defined surface topographies, such as surface-structured films 
or non-woven mats, on both of which good cell adhesion and proliferation could be detected due to the precisely 
controlled topography, dimensions and its increased surface area[42,43]. As a second approach, genetically 
modifying eADF4(C16) with the cell-binding motif RGD (Arginine-Glycine-Aspartate) promoted mammalian cell 
adhesion and proliferation with good cell viability in 2D and 3D materials.[44,45] Interestingly, even without 
sterilization, surfaces of materials based on the used recombinant spider silk protein eADF4(C16) were 
commonly free of microbes.[46,34]  
To systematically analyze microbe repellence, an extensive study was performed applying a diverse selection of 
different biofilm forming microbes, representing pathogenic bacteria (S. mutans, S. aureus, E. coli) and fungi (C. 
albicans, P. pastoris) (Figure 1A). Unlike the complex mixture/composite of natural spider silk fibers, 
recombinant technologies provide pure and perfectly defined proteins and materials made thereof, which are 
intrinsically non-toxic. Consequently, it was hypothesized, that anti-fouling effects of spider silk surfaces might 
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not be attributed to toxic effects or explicit amino acid sequences, but to nano-structural features. Numerous 
technical[47,48] as well as natural[49,50] examples have shown the achievement of anti-fouling properties by nano-
scaled topographies (Figure 1B).[51] Here, biotechnological design and recombinant production of different 
spider silk proteins was applied as a platform technology to systematically study the impact of the β-sheet 
structure-based nano-crystallites concerning anti-fouling performance (Figure 1C). To test the hypothesis of 
nano-topographical effects leading to microbe-repellence, we investigated the impact of the bio-functionalization 
with a cell-binding motif (RGD), which doesn’t change the basic crystallite-structural features of eADF4(C16) and 
has the potential of bio-selective mammalian cell growth with simultaneous microbe repellence (Figure 1C: a1, 
a3). To evaluate the impact of molecular weight as well as terminal domains, eADF4(C32NR4) was included 
within this study as its non-repetitive terminal domain causes dimerization resulting in an apparent MW of 208 
kDa (Figure 1C: a2). As no structural differences between the core-domains of these proteins and that of 
eADF4(C16) could be detected,[36] anti-fouling properties were expected to be the same.  
On the other hand, structural changes and thus changed microbe-repellent properties were predicted to be 
induced by varying charges or different amino acid sequence motifs. To analyze the impact of charge, all 
negatively charged glutamic acid residues (E) in the consensus sequence of eADF4(C16) were replaced by 
uncharged glutamine residues (Q), resulting in the so far not examined neutral recombinant spider silk variant 
eADF4(Ω16) (Figure 1C: a4). We predicted, that loss of electrostatic repulsion would impact the homogeneous 
crystalline distribution as found in the eADF4(C16) structure leading to rather heterogenous packing, clustering 
and distribution of β-sheet structures in eADF4(Ω16)-based materials. Although, the fibroin 3-based protein 
variant eADF3(AQ)12 is also uncharged, the amino acid sequence significantly differs in length of the polyalanine 
as well as glycine-rich sequence motif with direct implications on β-sheet size/crystallite size as well as 
amorphous regions (Figure 1C: b1). It could be expected that the larger amorphous regions in eADF3(AQ)12 
sterically separate the crystal parts, leading to a more homogeneous distribution of crystals similar to those 
found in eADF4(C16), which are based on electrostatic repulsion (Figure 1C: b1). 
 Importantly, recombinant spider silk proteins can be processed into solid morphologies such as films 
(representing the potential use as coatings of medical devices or bio-plastic foils as packaging materials)[41,52,53] 
or soft hydrogels (which are highly relevant in the fields of tissue engineering and biofabrication).[54-56] Thus, the 
experimental design included the use of smooth and structured films as well as hydrogels. For comparison, 
regenerated B. mori fibroin was included representing a non-spider silk type with a significantly different amino 
acid sequence and respective slightly different structural features and therefore crystal size, poly(caprolactone) 
(PCL) as a broadly applied biopolymer and gelatin, a protein-based material which is often used in the context of 
biofabrication (i.e. 3D-bioprinting together with cells). To explicitly analyze their suitability in the field of 
biofabrication and tissue engineering, the bio-selectivity of 2D and 3D materials made of recombinant spider silk 
proteins was tested in co-culture experiments including microbes and fibroblasts.  
2. Results  
Bacteriostatic and fungistatic properties of recombinant spider silk films 
To systematically investigate the absence of microbes and the putative bacteriostatic and fungistatic properties 
of distinct spider silk surfaces, films of the negatively charged recombinant spider silk proteins eADF4(C16) and 
eADF4(C32NR4) and the uncharged eADF4(Ω16) and eADF3((AQ)12) were fabricated to test the influence of 
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the primary structure, molecular weight, net charge and the presence of a terminal assembly domain (Table S1, 
Supporting Information) on microbial adhesion.  
At first, we investigated the single bacterial adhesion forces in contact with 2D spider silk surfaces. The forces 
involved in bacterial adhesion were quantified by atomic force microscopy (AFM) in force spectroscopy mode 
using single cell bacterial probes.[57,58] Methicillin-resistant Staphylococcus aureus strain (MRSA) is a 
widespread problem in hospitals and is a highly infectious pathogen responsible for numerous fatalities 
worldwide. A single S. aureus cell was immobilized on a tipless AFM cantilever and pressed with a maximum 
force of 300 pN onto silanized glass slides coated with eADF4(C16), eADF4(C32NR4), eADF4(Ω16), 
eADF3((AQ)12), B. mori fibroin, and PCL, the latter two acting as controls. Direct contact was allowed for some 
microseconds (termed 0 s in the following) or additional 5 s of surface delay time before the single bacterium 
was lifted and the adhesion force Fad was measured. Then, the forces were normalized (Fad (bacteria) / adhesion 
force on uncoated silanized glass Fad (glass)), and the statistically weighted mean adhesion force was determined. 
Thereby, the microbe-repellent properties of recombinant spider silk films of eADF4(C16), eADF4(C32NR4), and 
eADF3((AQ)12), yielded an extremely low bacterial adhesion force (Figure 2A). The initial adhesive force at 0 s 
was slightly, but significantly higher on eADF4(Ω16) (factor ~4.5) and even higher on surfaces of B. mori fibroin 
(factor ~28) and of PCL (factor ~168) in comparison to that of eADF4(C16). At a surface delay time of 5 s, the 
adhesive forces increased in all cases, but still adhesion forces on the three recombinant spider silk protein-
based films (eADF4(C16), eADF4(C32NR4), and eADF3(AQ)12,) were significantly lower than on the control 
materials (B. mori fibroin and PCL). To the best of our knowledge, this bacteriostatic and fungistatic properties of 
materials made of recombinant spider silk are unique, as materials prepared from regenerated B. mori fibroin, 
which resemble to some extend the composition and properties of spider silk proteins but not the amino acid 
sequence, do not show such behavior. 
Next, we investigated biofilm formation on 2D-surfaces using E. coli and P. pastoris, this time also including an 
RGD-modified variant of eADF4(C16). Microbial viability was quantified using the CellTiter-Blue assay. The 
negligible adhesion of E. coli and P. pastoris on eADF4(C16), eADF4(C32NR4), and eADF3((AQ)12) as well as 
eADF4(C16)-RGD films resulted in low fluorescence intensity in comparison to that of consolidated biofilm 
formation on eADF4(Ω16), B. mori fibroin and PCL films with much higher microbial viability (Figure 2B). These 
results clearly indicated that explicit spider silk surfaces do not allow efficient adhesion of E. coli and P. pastoris, 
an observation that is complementary to the previous quantitative adhesion force measurements using S. 
aureus.  
This finding is intriguing, since the amino acid building blocks between the different silk proteins are similar with 
only slight differences. However, these differences are the basis of distinct structural features with significant 
impact on protein folding and self assembly. The microbe-repellent properties of these different silks seem to be 
directly based on these structural features. To confirm that microbe-repellance is based on structural but not 
topographical features, flat spider silk films were compared to micro-patterned ones (2 μm wide grooves, 1 µm 
wide and 4 µm high ridges) concerning microbial adhesion. The surface topography of spider silk films has 
previously been shown to influence mammalian cell attachment and proliferation making this experiment 
important.[42] Suspended cariogenic Streptococcus mutans (S. mutans) as well as pathogenic Candida albicans 
(C. albicans) were seeded on top of all smooth and patterned films for 12 h at 37 °C. After washing to remove 
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non-adherent pathogens, films were air dried for microscopic analysis of microbial growth. Scanning electron 
microscope (SEM) images clearly showed that both smooth and patterned eADF films substantially restricted the 
attachment, growth and microbial colonization of S. mutans as well as C. albicans, and confirmed the superior 
repellence of spider silk 2D films (exemplarily shown are eADF4(C16) films) as compared to PCL ones (Figure 
2, C-F). This finding confirmed the strict dependence of microbe adhesion to protein-structural surface pattern 
but not on surface topography, which was surprising since the grooves were expected to provide optimal niches 
for bacterial and fungal physical attachment, being thought to provide at least some impact on microbe 
adhesion. The microbe-repellence structural features were overruling any effect that the topography would 
normally have, which was also exhibited in the control groups. This property could have far-reaching impact on 
future applications, as C. albicans is an opportunistic, common fungal pathogen found in hospitals and is known 
to be highly infectious and life threatening. Additionally, E. coli and P. pastoris cells were tested concerning their 
adhesion to all recombinant spider silk protein-based films and could not attach to either smooth and patterned 
films (Figure S1, Supporting Information).  
Next, it was investigated whether this protein structure-based bacteriostatic and fungistatic properties are 
restricted to the surface of explicit spider silk films or if they are generic, that is, the feature is retained when 
other spider silk morphologies (with identical protein structures) are prepared, such as hydrogels. Spider silk 
proteins can be processed into shear thinning hydrogels which can be 3D printed,[45] and one possible 
application is their use as scaffolds in tissue regeneration. Therefore, bacteriostatic and fungistatic properties 
would complement other interesting features such as non-toxicity and biodegradability of recombinant spider silk 
hydrogels.[53,38,39] These properties, in combination with a controllable adhesion of mammalian cells, would boost 
their applicability in various biomedical applications. 
Bacteriostatic and fungistatic properties of spider silk hydrogels  
To monitor their bacteriostatic and fungistatic properties, spider silk hydrogels were incubated with E. coli and P. 
pastoris for 24 h at 37 °C. As a control, hydrogels of regenerated B. mori fibroin[59] and gelatin[60] as a further 
commonly used biomaterial were incubated in an identical manner. Subsequently, all hydrogels were washed 
carefully to remove non-adherent bacteria, and an alamar blue viability assay was used to determine E. coli and 
P. pastoris. Spider silk hydrogels with microbes showed little alamar blue fluorescence, exemplarily shown for 
eADF4(C16) and eADF4(C16)-RGD (Figure 3A). SEM images of lyophilized hydrogels clearly indicated that 
bacteria and fungi were not adhering and growing on and within recombinant spider silk hydrogels (Figure 3, B 
(i-ii) and C (i-ii)) even upon incubation for 10 days (Figure S2, Supporting Information). Importantly, in this 
study, adhesion of microbial cells to eADF4(Ω16) hydrogels endorsed the microbe-repellence structural features 
of spider silk in 3D surfaces as well to some extent (Figure 3, A, D (i-ii)). However, it can be clearly seen that B. 
mori fibroin and gelatin hydrogels enabled E. coli and P. pastoris cells to adhere and colonize, (Figure 3, A, E (i-
ii) and F (i-ii)). On and within both B. mori fibroin and gelatin hydrogels, microbial biofilms could be easily 
detected.  
Bio-selective properties of spider silk films and hydrogels  
Since the identified bacteriostatic and fungistatic properties of distinct spider silk materials can be distinguished 
from the previously determined topography-dependent adhesion of mammalian cells, we wanted to elucidate 
whether it is possible to trigger a bio-selective behavior, which represses the growth of microbes but enhances 
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mammalian cell attachment and proliferation. To improve mammalian cell adhesion, we used eADF4(C16)-RGD 
known to interact with integrin receptors to promote mammalian cell attachment.[44,45,55] Importantly, all other 
physicochemical characteristics of this variant are indistinguishable to that of eADF4(C16) including pronounced 
bacteriostatic and fungistatic properties to resist biofilm formation as shown above. 
Hydrogels made of eADF4(C16) and eADF4(C16)-RGD were used to encapsulate BALB/3T3 fibroblasts, and 
these were seeded with E. coli and P. pastoris for 6 h to mimic a situation similar to that of a post-operative 
infection (Figure S3, Supporting Information). After 6 h of incubation, hydrogels were washed carefully to 
remove non-adherent cells (mammalian as well as microbial), and the hydrogels were further incubated with 
fresh cell culture media. Viability of microbes and fibroblasts was evaluated by microscopy and live/dead staining 
after 3, 6, and 10 days of incubation (Figure 4, (A-i) – (A-iii), (B-i) – (B-iii), (C-i) – (C-iii), and (D-i) – (D-iii)). 
Encapsulated fibroblasts showed good viability within the hydrogels made of eADF4(C16) and eADF4(C16)-
RGD over a culture period of 10 days (Figure 4E), while no bacterial and fungi growth/contamination could be 
detected during the entire cultivation period (Figure 4F and G), since the microbes could not adhere to start 
colony formation and did not manifest a biofilm. As expected, introduction of the RGD-sequence stimulated the 
proliferation of BALB/3T3 fibroblasts in contrast to eADF4(C16) hydrogels in which very little proliferation was 
observed.  
3. Discussion 
Microbial adhesion tests with different pathogenic microorganisms using both bacteria (S. mutans, S. aureus, 
and E. coli) and fungi (C. albicans, and P. pastoris) demonstrated microbe repellence of distinct recombinant 
spider silk materials. None of the tested microbes could manifest biofilms on selected recombinant spider silk 
films, hydrogel surfaces or within hydrogels. The inherent property of bacteriostatic and fungistatic performance 
of distinct spider silk materials was speculated to be related to the structural features of the underlying proteins 
responsible for the formation of hydrophobic patches.[61] The used protein platform technology (Figure 5I), 
confirmed the correlation of adhesion of microorganisms with the arrangement of protein secondary structures 
(i.e. hydrophobic patches) (Figure 5II, and III). As shown schematically, based on the primary sequence, the 
size and homogeneous distribution of hydrophobic patches can be controlled due to either intermolecular 
charge-charge repulsion as in eADF4(C16) and eADF4(C32NR4) or volume effect of the amorphous region in 
eADF3(AQ)12. In contrast, the absence of charge in eADF4(Ω16) was hypothesized to induce a denser and less 
homogeneous packing of nano ß-crystallites, creating large-enough anchoring sites for microbes. On the 
mesoscale, microbial cell attachment most readily occurs on surfaces which are rougher, more hydrophobic and 
positively charged. Distinct silk proteins, such as spider silk and silkworm silks, feature structural differences e.g. 
concerning the β-sheet crystallite size (spider silk: ~7 nm, B. mori fibroin ~14-200 nm) and crystallite 
orientation,[43,44] both influencing the dimensions of the respective hydrophobic patches. Our study demonstrated 
that 2D and 3D surfaces of B. mori fibroin with larger hydrophobic patches than that of spider silk are easily 
accessible for microbial manifestation. RGD-modified spider silk with homogeneous hydrophobic patches 
allowed selective mammalian cell adhesion and proliferation, with concomitant repellence of microbes. 
In comparison to natural spider silk with its composite surface layer. It is highly interesting that no additional 
components such as glycoproteins, lipids or antimicrobial agents but only the structural features of individual 
recombinant spider silk proteins are necessary to generate a microbe-repelling spider silk surface. To the best of 
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our knowledge, this is a completely new finding which opens the door for novel applications of spider silk 
materials, e.g., as bioselective coatings in various biomedical applications.  
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Acronyms  
eADF4                         engineered Araneus diadematus Fibroin 4 
B. mori                         Bombyx mori 
PCL                               poly(caprolactone) 
S. aureus                       Staphylococcus aureus 
E. coli                           Escherichia coli  
P. pastoris                    Pichia pastoris  
C. albicans                   Candida albicans 
S. mutans                     Streptococcus mutans 
AFM                            atomic force microscopy 
 
Experimental Section  
Protein design and production of recombinant spider silk proteins: eADF4(C16) was purchased from AMSilk 
GmbH (Planegg, Germany). The recombinant spider silk proteins eADF4(C16)-RGD, eADF4(C32NR4) and 
eADF3(AQ)12 were produced and purified as described previously.[36,44] To generate the uncharged eADF4(Ω16) 
variant, the glutamic acid residues (E) of the consensus sequence of eADF4(C16) were exchanged with 
glutamine (Q) ones. The recombinant spider silk protein eADF4(Ω16) was produced in E. coli BL21 gold (DE3) 
and purified following a protocol as described previously.[36] Briefly, after cell disruption eADF4(Ω16) was purified 
using a heat step and an ammonium sulfate precipitation. 
Bombyx mori (B. mori) fibroin protein: Regenerated fibroin solutions were prepared as described previously[59] by 
dissolving degummed (boiled for 30 min in 0.02M sodium carbonate) silk fibres in 9.3 M LiBr solution, dialysis 
against ultrapure water (Milli-Q) for 2 d at 4 °C, centrifugation at 8500 rpm for 45 min at 4 °C, and collection of 
the supernatant. The B. mori fibroin solutions had a final concentration of ~6% w/v and were stored at 4 °C until 
use. For the production of flat and patterned films, solutions were freeze-dried and processed in the same way 
as spider silk and PCL.  
 
Production of flat and patterned films: All flat and patterned films of proteins and polycaprolactone (PCL; 
Perstorp AB) were produced by film casting onto patterned polydimethylsiloxane (PDMS; Sylgard 184 Silicone 
Elastomer, Dow Corning) substrates. PDMS stamps were produced by casting of a 10:1 mixture of PDMS pre-
polymer and curing agent (degassed for 20 min) on a photo-lithographically patterned waver to generate the 
desired geometry (12 x 12 mm area with 2 μm wide grooves, ridges with a width of 1 μm and a height of 4 μm). 
After curing at 80 °C for 90 min, the stamps were solidified and could be easily peeled off. To produce patterned 
films, proteins and PCL were dissolved in 1,1,1,3,3,3,-hexafluoro-2-propanol (HFIP; Alpha Aesar) at a 
concentration of 100 mg/mL (room temperature, overnight). To generate films with a thickness of 10-15 µm, 250 
µL of solution (corresponding to 25 mg of protein/polymer) were poured into the stamp, and the solvent was 
subsequently evaporated at room temperature. The dried patterned films were removed and post-treated with 
100% ethanol for 1 h to render the silk protein water insoluble upon induction of β–sheet structures. To ensure 
that only material properties determined the results of microbial growth experiments, all samples (including PCL 
films) were treated the same way. After post-treatment, the samples were stored sterile in 70 % ethanol at 4 °C.  
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Bacteria and yeast culture on films: (a) Streptococcus mutans (DSMZ 20523, Braunschweig) and Candida 
albicans (patient isolate), stored at -80 °C, were thawed at RT, fractionally spread on Columbia blood agar (PB 
5039A, oxoid, Wesel) and incubated for 48 h at 37 °C and 5 % CO2. Afterwards, an overnight culture was 
prepared in BBLTM Schaedler Broth medium (Becton Dickinson, Sparks MD, USA), and then the culture was 
diluted (1:10) with Schaedler Broth medium. (b) Escherichia coli BL21(DE3)-gold (Novagen, Merck, Darmstadt, 
Germany), stored at -80 °C, was thawed at RT and inoculated in Luria–Bertani medium (LB), at 37 °C with 
constant shaking at 150 rpm until an optical density (OD600) between 0.8 and 1 was reached (corresponding to a 
viable count of approx. 107 –108 CFU mL−1). The E. coli culture was diluted (1:10) with LB medium. (c) Pichia 
pastoris X33 (wild type, Invitrogen, Germany) was inoculated in YPD-media and allowed to grow for 24 h at 
30 °C with constant shaking at 150 rpm. The P. pastoris culture was diluted (1:10) with YPD medium. 
Silk and polymer films were taken out of 70 % ethanol, subsequently washed with PBS (8.18 g NaCl, 0.2 g KCl, 
0.24 g anhydrous KH2PO4, 1.78 g Na2HPO4 x 2H2O, 1 L distilled water, pH 7.4, Sigma Aldrich, St. Louis, 
Missouri, USA), and incubated in 5 mL of diluted microbial solution (as described above) in petri dishes (Ø 5 cm) 
for 60 h (5 % CO2, 37 °C). Then, the films were removed and carefully washed with PBS to remove non-
adherent bacteria and yeast cells and dried at room temperature for subsequent SEM imaging. (d) For adhesion 
force measurements, Staphylococcus aureus (strain SA113), stored at -20 °C, was thawed and cultured for three 
days at 37 °C on blood agar plates. Then, one colony from a plate was transferred into 5 mL of sterile tryptic soy 
broth (TSB) and cultured overnight at 37 °C, 150 rpm agitation. For each experiment, 40 µL of the culture were 
transferred into 4 mL fresh TSB and cultured for another 2.5 h at 37 °C. The bacterial culture was washed three 
times with sterile phosphate buffered saline (PBS). The final suspension of bacteria in PBS was stored at 4°C 
and used no longer than 6 hours. 
 
Adhesion force measurements: Single S. aureus cells were attached to a tipless AFM cantilever (MLCT-0 with a 
nominal spring constant of 0.03 N/m from Bruker Nano, Santa Barbara, Ca, USA) coated with polydopamine that 
were calibrated before each set of experiments.[57,58] Force-distance measurements were performed using a 
Bioscope Catalyst from Bruker-Nano in PBS at room temperature. The maximum force with which the cells were 
pressed onto the surfaces was set to 300 pN. On each surface, 25 force-distance curves were performed for 0 s 
and 5 s of additional surface delay time with one and the same cell, the total number of individual cells being 
twelve. The results obtained from three of these cells were not used for the analysis as their adhesion forces 
were less than 5 % of the mean adhesion force of the remaining cells indicating that the adhesive strengths of 
these cells were not representative for the totality of S. aureus cells used. Nine more cells were tested on 
eADF4(C16), B. mori fibroin, and PCL with identical parameters under the same conditions. Approaching speed 
towards the surfaces was set to 800 nm/s for 0 s of surface delay time and 100 nm/s for 5 s of surface delay 
time. Retraction speed was 800 nm/s. To test the results of adhesion measurements for statistical significance, 
all adhesion force distributions were analyzed in pairs by a Man-Whitney-U-test with the software Matlab. 
Bacterial and yeast cell viability: Adhesion of E. coli and P. pastoris to silk and polymer films or hydrogels after 
culturing for 24 h at 37 °C was measured by analysis of cell vitality using the CellTiter-Blue assay. Samples 
incubated with bacterial and yeast cells were washed with phosphate buffered saline (PBS; Sigma-Aldrich) three 
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times, and then incubated with 10 % CellTiter-Blue (Promega) in PBS for 3 h at 37 °C. Transformation of the 
blue fluorescent dye resazurin into red fluorescent resorufin (λex = 530 nm; λem = 590 nm) was measured using a 
plate reader (Mithras LB 940, Berthold, Bad Wildbad) with counting time of 0.5 s. 
 
Preparation of eADF4(C16), eADF4(C16)-RGD and eADF4(Ω16) hydrogels: Lyophilized eADF4(C16) and 
eADF4(C16)-RGD were dissolved in 6 M guanidinium thiocyanate (GdmSCN) at 5 mg/mL and dialyzed against 
10 mM Tris/HCl, pH 7.5 overnight at room temperature using dialysis membranes with a molecular weight cutoff 
of 6–8 kDa. Subsequent dialysis against 20 % w/v poly (ethylene glycol) (PEG, 20,000 g/mol) at a volume ratio 
of PEG/eADF4(C16) solution of 100:1 was used to remove water by osmotic pressure and to adjust 30 mg/mL 
(3 % w/v) spider silk solutions. Hydrogels were self-assembled after an overnight incubation at 37 °C. For the 
preparation of eADF4(Ω16) hydrogels, all steps were carried out at 4 °C, and hydrogels were prepared at 
concentration of 20 mg/mL (2 % w/v) eADF4(Ω16). 
For co-culture experiments, 1x106 BALB/3T3 fibroblasts were added to 3 % w/v eADF4(C16) and eADF4(C16)-
RGD spider silk solutions before gelation in an incubator at 37 °C. 
 
Preparation of B. mori fibroin hydrogels: B. mori fibroin hydrogels were prepared using sonication induced 
gelation, as previously reported.[59] In brief, 4 % (w/v) aqueous silk fibroin solution in a 15 mL conical tube was 
ultra-sonicated (Ultrasonic Homogenizers HD 3100, BANDELIN) at 50 % amplitude (21 W) for 30 s, and 
overnight incubation at 37 °C induced gelation. 
Preparation of gelatin hydrogels: GelMA was produced upon reacting gelatin solutions (gelatin from bovine skin, 
Type B, ∼225g Bloom, Sigma-Aldrich) with methacrylic anhydride (Sigma-Aldrich) following previously described 
protocols.[60] After the dissolution of 10 % (w/v) gelatin in 0.1M CB buffer (3.18 g sodium carbonate and 5.86 g 
sodium bicarbonate in 1L distilled water) at 60 °C, one sixth of 1 % (v/v) methacrylic anhydride was added 
dropwise every 30 min for 3 h. The solution was vigorously stirred for another 1 h, diluted with 0.1M CB, and 
dialyzed for 2 days against ultrapure (Milli-Q) water at 37 °C. The solution was then freeze-dried in a lyophilizer 
to obtain methacrylamide-modified gelatin as a dry white powder.  
Methacrylamide-modified gelatin hydrogel was obtained by UV exposure of 5 % (w/v) GelMA solution in 24 well 
cell culture vessels at 365 nm using an ultraviolet lamp (Benda, type NU -4 KL) for 15 min in the presence of 0.5 
mg/mL of the photoinitiator 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure- 2959, Sigma-
Aldrich). 
 
Bacteria and yeast culture with hydrogels: Hydrogels were incubated with 1 mL of diluted liquid cultures of E. coli 
and P. pastoris for 12 h at 37 °C. Hydrogels were washed with phosphate buffered saline (PBS; Sigma-Aldrich) 
three times to remove non-adherent bacteria and yeast cells and then lyophilized. 
Microbial adhesion: The anti-adherence activity of eADF4(C16) and eADF4(C16)-RGD hydrogels concerning E. 
coli and P. pastoris was measured by inoculating the supernatant (100 µL) of the microbe-treated hydrogels 
(after washing) in fresh media and culturing for additional 12 h at 37 °C. Optical density at 600 nm (OD600; 
OD600 DiluPhotometer™, IMPLEN) was measured to monitor microbial growth/infection. 
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BALB/3T3 cultivation: BALB/3T3 mouse fibroblasts (European Collection of Cell Cultures) were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM, Biochrom) supplemented with 10 % fetal bovine serum (Biochrom) 
and 1 % (v/v) GlutaMAX (Gibco) in a controlled atmosphere of 5 % CO2, 95 % humidity and at 37 °C. Viability 
and number of cells were analyzed using trypan blue (Sigma-Aldrich) in a Neubauer chamber (Laboroptik, UK). 
Co-culture experiments with hydrogels: eADF4(C16) and eADF4(C16)-RGD hydrogels with encapsulated 
BALB/3T3 mouse fibroblasts (i.e. bioinks) were prepared in hanging cell culture inserts using 24-well plates 
(Merck Millipore) and then exposed to diluted (1:10, corresponding to OD 0.25) bacterial and yeast cells 
prepared in DMEM for 6 h at 37 °C with 80 % relative humidity. Hydrogels were washed three times to remove 
non-adherent microbes and incubated with fresh DMEM media and cultivated for 10 days under identical 
conditions. Cell culture medium was changed every 24 h. The cell viability of BALB/3T3 mouse fibroblasts was 
analyzed using the Live/Dead assay after 3, 6 and 10 days. 
Live/Dead assay: Films and hydrogels of eADF4(C16) and eADF4(C16)-RGD were washed with PBS and 
stained with Calcein acetoxymethylester (Calcein A/M, Invitrogen) and Ethidium Homodimer-1 (EthD-1, 
Invitrogen) in cell culture medium for the detection of live and dead cells, respectively. Calcein A/M was added to 
the medium at a final concentration of 0.3 μM, and Ethidium Homodimer-1 was added to the medium at a final 
concentration of 0.1 μM and incubated for 30 min. After staining, the solution was removed, and fresh PBS was 
added for imaging. Live and dead cells were visualized and analyzed using a fluorescence microscope (Leica 
DMi8, Wetzlar) and processed using either Leica Application Suite or Image J. 
 
Scanning electron microscopy (SEM): To analyze the morphological structure using SEM, hydrogels were 
lyophilized and fixed to SEM stubs using conductive carbon cement solution (Leit-C, PLANO GmbH). Samples 
were sputter-coated with 2 nm platinum (Sputter Coater 208 HR with 268 MTM 20, Cressington, Watford, U.K.) 
and then imaged at an accelerating voltage of 2.5 kV using a scanning electron microscope 270 Zeiss Sigma VP 
300 (Zeiss, Oberkochen, Germany) and Field Emission Gun (FEG; Apreo VS, ThermoFisher Scientific/FEI, 
Germany). 
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Figure 1. Schematic overview of the conceptual strategy to prevent biofilm formation using spider silk 
materials. Various biofilm-forming microbes representing pathogenic bacteria and fungi (A) as well as P. pastoris 
(model system) were chosen to verify previously established concepts of passive biofilm prevention by nano-
structured surfaces (B) using the engineered recombinant spider silk platform technology (C). It is predicted that 
particularly the charge and the amino acid sequence contributes to the homogeneity of crystallite size and 
distribution. Biotechnological engineering allows for systematic adaption of e.g. molecular weight (a1 vs. a2) and 
bio-functionality (a1 vs. a3) not affecting the crystallite properties of the underlying silk proteins. On the other 
hand, changes such as charge (a1 vs. a4) or amino acid sequence (a1 vs. b1) are expected to impact crystallite 
size and distribution. Combining microbe-repellant structural features with the ability to modify the intrinsically 
bio-compatible spider silk proteins with cell-adhesion motifs (a3) resulted in distinct bio-selective 2D and 3D 
spider silk materials. 
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Figure 2. Bacteriostatic and fungistatic properties of 2D scaffolds made of recombinant spider silk 
proteins. (A) Adhesion force measurements using single S. aureus probes on silanized glass coated with 
eADF4(C16), eADF4(C32NR4), eADF4(Ω16), eADF3((AQ)12), B. mori fibroin, and PCL, the latter two serving as 
controls. Representative normalized mean adhesion forces were obtained from 25 force-distance curves 
performed on each surface for 0 s (brown) as well as 5 s (green) surface delay time using one and the same cell 
immobilized on a cantilever with a nominal spring constant of 0.03 N m−1. Forces were referred to the values 
measured on uncoated silanized glass (4.8 ± 2.4 nN). It was detected that all distributions of adhesion forces 
were significantly different with p values below 0.001. (B) Viability of E. coli and P. pastoris cells on films of 
eADF4(C16), eADF4(C32NR4), eADF4(C16)-RGD, eADF3((AQ)12), B. mori fibroin, and PCL, after incubation for 
24 h at 37 °C. Microbial viability was quantified using the CellTiter-Blue assay by measuring the transformation 
of the blue fluorescent dye resazurin into red fluorescent resorufin using 530 nm excitation and 600 nm emission 
filters in a microplate reader. Each result is an average of five experiments, and the error bars designate the 
standard deviations. Student's t-test was performed for statistical analysis, *indicates significant difference to 
eADF4(C16) (p < 0.05). Exemplarily SEM images showing (i) plane and (ii) micro-patterned surfaces of (C & E) 
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eADF4(C16) and (D & F) PCL after 12 h of incubation with (C & D) S. mutans and (E & F) C. albicans at 37 °C. 
Scale bars = 5 µm.  
 
Figure 3. Bacteriostatic and fungistatic properties of spider silk hydrogels made of eADF4(C16). (A) 
Viability of microbial cells on hydrogels made of eADF4(C16), eADF4(C16)-RGD, eADF4(Ω16), B. mori fibroin 
and gelatin after 24 h incubation with E. coli and P. pastoris at 37 °C. Microbial viability was quantified using the 
alamar blue assay by measuring the transformation of the blue fluorescent dye resazurin into red fluorescent 
resorufin with 530 nm excitation and 600 nm emission filters in a microplate reader. Minimal adhesion of E. coli 
and P. pastoris on eADF4(C16) and eADF4(C16)-RGD hydrogels resulted in low fluorescence intensity in 
comparison to adhesion on eADF4(Ω16), B. mori fibroin and gelatin hydrogels with higher microbial viability. 
Each result is an average of three experiments, and the error bars designate the standard deviations. Student's 
t-test was performed for statistical analysis, *indicates significant difference to eADF4(C16) (p < 0.05). SEM 
images of hydrogels prepared from (B) eADF4(C16), (C) eADF4(C16)-RGD, (D) eADF4(Ω16), (E) B. mori fibroin 
and (F) gelatin after 24 h of incubation with (i) E. coli and (ii) P. pastoris. Arrows show biofilm or microbial cells on 
hydrogels. Scale bars = 2 µm. 
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Figure 4. Bacteriostatic and fungistatic properties of 3D scaffolds made of eADF4(C16) in co-culture of 
microbes and mammalian cells. Fluorescence images of (A and B) eADF4(C16) and (C and D) eADF4(C16)-
RGD hydrogels with encapsulated BALB/3T3 fibroblasts and co-cultured with (A and C) E. coli and (B and D) P. 
pastoris for (i) 3 days, (ii) 6 days, and (iii) 10 days. Scale bars = 100 µm. The cells were stained with calcein A/M 
(live cells: green) and ethidium homo dimer I (dead cells: red). Ethidium homodimer I also stained the hydrogels 
yielding an unspecific red background fluorescence (A–D). Proliferation of mouse fibroblastss (BALB/3T3) in 
coculture over 10 days was measured using (E) the absorbance of cell titer blue. Microbial growth of E. coli and 
P. pastoris in fresh media was measured using (F and G) optical density at 600 nm (OD600) with microbial 
inoculated hydrogels (after washing) and after incubation for 12 h at 37 °C. Each result is an average of three 
experiments, and the error bars designate the standard deviation. Student's t-test was performed for statistical 
analysis, *p < 0.05.  
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Figure 5. Schematic illustration of the microbial behaviour on the hydrophobic patches of silk with (1) repellant / 
non-repellent and (2) bioselective surfaces. (I) Recombinant spider silk variant / silk worm silk, (II) β-sheet 
formation yields hydrophobic surface patches with unique distribution and dimensions. (III) Homogeneous 
hydrophobic patch distribution of eADF4(C16), dimeric eADF4(C32NR4), and eADF3((AQ)12) shows microbe 
repellence characteristics. The absence of charge-charge repulsion or steric effects in eADF4(Ω16) leads to the 
dense packing of hydrophobic patches or structured larger hydrophobic patches in B. mori fibroin favouring the 
attachment of microbial cells. eADF4(C16)-RGD allows selective mammalian cell attachment with simultaneous 
microbe repellance. 
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Materials based on engineered spider silk proteins are resistant to attachment of pathogenic bacteria and fungi, 
and efficiently inhibit biofilm formation. Films and hydrogels made of a RGD-modified spider silk variant allow for 
selective attachment and proliferation of mammalian cells in co-culture with microbes, while the microbes are 
non-adherent and easily washed off. 
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Figure S1. Bacteriostatic and fungistatic properties of films made of eADF4(C16). SEM images showing (i 
& iii) plane and (ii & iv) micro-patterned surfaces of films made of (A) eADF4(C16), (B) eADF4(C32NR4), (C) 
eADF4(C16)-RGD, (D) eADF4(Ω16), (E) eADF3(AQ)12, (F) B. mori fibroin and (G) PCL after 12 h of incubation 
with (i & ii) E. coli and (iii & iv) P. pastoris at 37 °C. Scale bars = 2 µm. 
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Figure S2. Bacteriostatic and fungistatic properties of hydrogels made of spider silk variants. Viability of 
E. coli and P. pastoris cells on hydrogels of (A) eADF4(C16) and (B) eADF4(C16)-RGD over 10 days was 
quantified using the CellTiter-Blue assay by measuring the transformation of the blue fluorescent dye resazurin 
into red fluorescent resorufin using 530 nm excitation and 600 nm emission filters in a microplate reader. Cell 
culture treated plates without coating were used as control. Each result is an average of five experiments, and 
the error bars designate the standard deviations. Student's t-test was performed for statistical analysis, *p < 
0.05. 
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Figure S3. Schematic illustration demonstrating the co-culture of microbes (E. coli and P. pastoris) and 
mammalian cells (BALB/3T3) within hydrogels of eADF4(C16) and eADF4(C16)-RGD. The cell viability of mouse 
fibroblasts (BALB/3T3) in co-culture with microbes was evaluated by cell staining with calcein A/M (live cells: 
green) and ethidium homodimer I (dead cells: red), and microbial growth of E. coli and P. pastoris in fresh media 
was measured using the optical density at 600 nm (OD600).  
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Table S1. Properties of recombinant spider silk proteins 
Recombinant spider silk 
protein 
Mw (kDa) No. of charged amino acid 
residues at neutral pH 
(positive/negative) 
pI 
eADF4(C16) 47.7 0/16 3.5 
eADF4(C32NR4) 104.1 2/34 3.5 
eADF4(C16)-RGD  48.5 1/17 3.6 
eADF4(Ω16) 48.0 0/0 7.8 
eADF3(AQ)12 48.0 0/0 5.5 
Charged amino acid residues refer to silk sequences only; the T7 tag, present in all  
constructs, comprises an additional arginine residue. 
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